{
  "meta": {
    "title": "00354_Late_Night_Pyq_Pyt_Obg-3",
    "url": "https://brainandscalpel.vercel.app/00354-late-night-pyq-pyt-obg-3-0315dd8f.html",
    "scrapedAt": "2025-11-29T17:29:25.973Z"
  },
  "questions": [
    {
      "id": 54775,
      "choices": [
        {
          "id": 218565,
          "text": "<p><span style=\"font-size:12.0pt;\">Mid cavity forceps</span></p>"
        },
        {
          "id": 218566,
          "text": "<p><span style=\"font-size:12.0pt;\">Low forceps</span></p>"
        },
        {
          "id": 218567,
          "text": "<p><span style=\"font-size:12.0pt;\">Outlet forceps</span></p>"
        },
        {
          "id": 218568,
          "text": "<p><span style=\"font-size:12.0pt;\">Ventouse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A primigravida is in the 2nd stage of labor for 2 hours. The head is at +3 with caput present and the fetal heart rate (FHR) is dropping to 90 bpm. What is the best way to deliver the head? (INICET MAY 2024)</span></p>",
      "unique_key": "Q8986970",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585219,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Outlet forceps</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this scenario, the patient is a primigravida (a woman pregnant for the first time) who is in the second stage of labor, which has been ongoing for 2 hours. The second stage of labor in a primigravida can be allowed up to 3 hours if the mother and fetus are stable. However, in this case, the fetal heart rate has dropped to 90 bpm, indicating fetal distress, and the head is at +3 station, meaning it is very low in the pelvis, almost at the pelvic floor.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Outlet forceps</strong> are specifically designed for situations where the fetal head is at +3 station or lower. The head is visible at the introitus without separating the labia, and delivery needs to be expedited due to fetal distress. In this case, the application of outlet forceps is preferred because it allows for a quicker delivery compared to other methods. This is critical when there is evidence of fetal distress, as time is of the essence to reduce the risk of hypoxia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mid cavity forceps</strong> are used when the fetal head is higher in the pelvis, typically at 0 to +1 station. This option is not suitable in this case because the head is much lower, at +3 station.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low forceps</strong> are used when the head is at +2 station, slightly higher than in this scenario. They are not appropriate when the head is at +3 station.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Ventouse (vacuum extraction)</strong> can be used at various stations, but it is generally slower to apply compared to forceps. Additionally, the presence of caput (swelling of the fetal scalp) can make it difficult to achieve the necessary suction for effective vacuum delivery. Therefore, outlet forceps are preferred in this scenario to ensure a quicker and more effective delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mid cavity forceps:</strong> Incorrect because they are used when the head is at a higher station, typically 0 to +1, and the head is not yet at the pelvic floor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Low forceps:</strong> Incorrect because they are more suitable when the head is at +2 station, not when it is already at +3 station.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ventouse (vacuum extraction):</strong> While it could technically be used, it is not the best choice here because of the fetal distress and the presence of caput, which may hinder the effective application of the vacuum.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In cases of fetal distress with the fetal head at +3 station, outlet forceps are the preferred method of assisted delivery due to their speed and effectiveness, particularly when caput is present.</span></p>",
      "correct_choice_id": 218567,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21767,
      "choices": [
        {
          "id": 87032,
          "text": "<p><span style=\"font-size:12pt;\">Metastasis endometrial carcinoma to ovary</span></p>"
        },
        {
          "id": 87033,
          "text": "<p><span style=\"font-size:12pt;\">Polycystic ovarian disease</span></p>"
        },
        {
          "id": 87034,
          "text": "<p><span style=\"font-size:12pt;\">Struma Ovarii</span></p>"
        },
        {
          "id": 87035,
          "text": "<p><span style=\"font-size:12pt;\">Immature ovarian teratoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 57-year-old woman has an endometrial thickness of 14 mm with an adnexal mass. A previous report of endometrial biopsy shows complex endometrial hyperplasia with the presence of atypical cells. What is the likely diagnosis?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q6531498",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585222,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Metastasis endometrial carcinoma to ovary</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">According to the given clinical scenario, patient most likely has Endometrial Carcinoma with metastasis to ovaries.</span></li><li><span style=\"font-size:12pt;\">Transvaginal scan (TVS) is done in women with post-menopausal bleeding. Normal Endometrial thickness in postmenopausal women is ≤ 4mm. Endometrial biopsy is indicated in women with post menstrual bleeding with endometrial thickness &gt; 5mm.</span></li><li><span style=\"font-size:12pt;\">The risk of progress to endometrial carcinoma in a patient with complex hyperplasia with atypia is 29%</span></li><li><span style=\"font-size:12pt;\">The most likely diagnosis would thus be endometrial cancer and with an adnexal mass would be an ovarian metastases</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/12/screenshot-2024-08-12-103858.png\" alt=\"\" width=\"1000\" height=\"219\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Polycystic ovarian disease</strong>: Diagnosis is based on the presence of 2 out of the following 3 criteria 1) Oligo and/or anovulation 2) Hyperandrogenism 3) Polycystic Ovaries on ultrasound.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Struma Ovarii</strong>: It is a rare type of ovarian teratoma containing thyroid tissue. Another type of monodermal teratoma is the strumal carcinoid secreting serotonin</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Immature ovarian teratoma</strong>: This is a rare usually malignant germ cell tumor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Endometrial thickness &gt; 5 mm in postmenopausal women with bleeding should prompt an endometrial biopsy, especially if complex hyperplasia with atypia is suspected due to the high risk of progression to endometrial carcinoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta Textbook of Gynaecology page 329, 460, 294</strong></span></p>",
      "correct_choice_id": 87032,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23224,
      "choices": [
        {
          "id": 92860,
          "text": "<p><span style=\"font-size:12pt;\">Uterine prolapse - Vaginal hysterectomy</span></p>"
        },
        {
          "id": 92861,
          "text": "<p><span style=\"font-size:12pt;\">Vault prolapse - Sacrospinous ligament suspension</span></p>"
        },
        {
          "id": 92862,
          "text": "<p><span style=\"font-size:12pt;\">Cystocele - Colposuspension</span></p>"
        },
        {
          "id": 92863,
          "text": "<p><span style=\"font-size:12pt;\">Rectocele - Posterior colporrhaphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following options is incorrectly matched?&nbsp;</span>(INICET MAY 2023)</p>",
      "unique_key": "Q6820595",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585248,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Cystocele - Colposuspension</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Anterior colporrhaphy is performed for cystocele.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-101304.png\" alt=\"\" width=\"1000\" height=\"420\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cystocele, the appropriate surgical management is anterior colporrhaphy, not colposuspension.</span></p>",
      "correct_choice_id": 92862,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23223,
      "choices": [
        {
          "id": 92856,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Degranulated neutrophils</span></span></span></p>"
        },
        {
          "id": 92857,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epithelial cells covered by bacteria </span></span></span></p>"
        },
        {
          "id": 92858,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardenella vaginalis with Bacillin rods </span></span></span></p>"
        },
        {
          "id": 92859,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Doderlein bacili in the macrophage</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 32-year-old woman comes in with a grayish-white vaginal discharge. Upon conducting a gram stain of the discharge, clue cells are observed. What are clue cells?&nbsp;</span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q8435202",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585245,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Epithelial cells covered by bacteria </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clue cells are epithelial cells that are covered by bacteria, which gives them a distinctive appearance. In the context of bacterial vaginosis, these cells appear with a fuzzy or irregular border due to the presence of small gram-negative bacilli adhering to their surface. The presence of clue cells is a hallmark of bacterial vaginosis, a condition caused by an imbalance in the normal vaginal flora.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Degranulated neutrophils</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Degranulated neutrophils are not clue cells. Neutrophils are involved in the immune response, and their degranulation refers to the release of granules that contain enzymes and other substances. They do not have the fuzzy appearance characteristic of clue cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Gardenella vaginalis with Bacillin rods</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Gardenella vaginalis is a bacterium associated with bacterial vaginosis, but clue cells are not specifically Gardenella vaginalis with Bacillin rods. Clue cells are epithelial cells covered by various types of bacteria, not a specific bacterium or rod-shaped bacteria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Doderlein bacilli in the macrophage</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Doderlein bacilli (lactobacilli) are normally present in the vagina and help maintain a healthy environment. They are not found within macrophages, nor are they related to the appearance of clue cells.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clue cells are epithelial cells covered by bacteria, and their presence is indicative of bacterial vaginosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/15/whatsapp-image-2023-06-12-at-190121011010201026_page_44.jpg\" style=\"height:374px; width:500px\" /></span></span></span></span></p>",
      "correct_choice_id": 92857,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56834,
      "choices": [
        {
          "id": 226729,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3 cm anterior to the posterior fontanelle</span></span></span></p>"
        },
        {
          "id": 226730,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6 cm anterior to the posterior fontanelle</span></span></span></p>"
        },
        {
          "id": 226731,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4 cm anterior to the posterior fontanelle</span></span></span></p>"
        },
        {
          "id": 226732,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Midway between the anterior and posterior fontanelle</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">You are applying a vacuum to deliver a baby in a patient with prolonged 2nd stage. The point at which the vacuum is applied is: (NEET PG 2024)</span></span></p>",
      "unique_key": "Q2109324",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585217,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 3 cm anterior to the posterior fontanelle</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Ans.</strong> is <strong>3 cm anterior to the posterior fontanelle</strong>, which is the location known as the <strong>flexion point</strong>. The flexion point is critical in vacuum-assisted deliveries because it lies 3 cm anterior to the posterior fontanelle on the baby&#39;s head. This point is chosen because pulling on this location causes flexion of the baby&#39;s head, facilitating the proper positioning for delivery. Flexion is crucial as it allows the smallest diameter of the baby&#39;s head to present, making the delivery process smoother and safer for both the mother and baby.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The flexion point, located 3 cm anterior to the posterior fontanelle, is the optimal site for applying a vacuum during delivery to achieve the necessary head flexion.</span></span></p>",
      "correct_choice_id": 226729,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "InstrumentsBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20484,
      "choices": [
        {
          "id": 81898,
          "text": "<p><span style=\"font-size:12pt;\">Chemotherapy</span></p>"
        },
        {
          "id": 81899,
          "text": "<p><span style=\"font-size:12pt;\">Brachytherapy</span></p>"
        },
        {
          "id": 81900,
          "text": "<p><span style=\"font-size:12pt;\">Chemoradiation</span></p>"
        },
        {
          "id": 81901,
          "text": "<p><span style=\"font-size:12pt;\">Surgery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 52-year-old woman presents with foul-smelling bloody discharge per vagina mixed with mucous discharge. On examination, a necrotizing growth is seen in the cervix with lateral parametrium involvement. What will be the management for this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q4896399",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585221,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Chemoradiation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient presents with a foul-smelling bloody discharge mixed with mucous discharge, and a necrotizing growth in the cervix with lateral parametrium involvement. These clinical features are suggestive of advanced cervical cancer. The involvement of the lateral parametrium indicates that the cancer has spread beyond the cervix to the surrounding tissues but not to the pelvic wall or the lower third of the vagina, which classifies it as Stage 2B cervical cancer. The standard treatment for Stage 2B cervical cancer is chemoradiation, which combines chemotherapy with radiation therapy. This approach aims to enhance the effectiveness of the treatment, reduce tumor size, and prevent further spread of the cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Chemotherapy:</strong> Chemotherapy alone is not the standard treatment for Stage 2B cervical cancer. It may be used in conjunction with radiation, but not as a sole therapy in this stage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Brachytherapy:</strong> Brachytherapy, a form of internal radiation therapy, is typically used for early-stage cervical cancer or in combination with external beam radiation therapy for more advanced stages. However, it is not sufficient as a standalone treatment for Stage 2B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Surgery:</strong> Surgery is generally not recommended for Stage 2B cervical cancer due to the extent of the disease spread to the parametrium. The preferred approach is chemoradiation to address both local and regional disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Stage 2B cervical cancer, characterized by lateral parametrium involvement, is best managed with chemoradiation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Staging of CA Cervix</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/10/screenshot-2024-08-10-180546.png\" alt=\"\" width=\"1000\" height=\"594\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">TREATMENT</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Surgery: for early stages like stage 1, stage 2A1</span></li><li><span style=\"font-size:12pt;\">Radiotherapy: for all patients from Stage 1 to 4</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/04/whatsapp-image-2023-06-12-at-1901210146.jpg\" alt=\"\" width=\"1000\" height=\"246\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Chemoradiation can be offered at all stages</span></p>",
      "correct_choice_id": 81900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44007,
      "choices": [
        {
          "id": 175687,
          "text": "<p><span style=\"font-size:12pt;\">Debulking followed by radiotherapy</span></p>"
        },
        {
          "id": 175688,
          "text": "<p><span style=\"font-size:12pt;\">Debulking followed by chemotherapy</span></p>"
        },
        {
          "id": 175689,
          "text": "<p><span style=\"font-size:12pt;\">Chemotherapy followed by debulking</span></p>"
        },
        {
          "id": 175690,
          "text": "<p><span style=\"font-size:12pt;\">Staging laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old woman with epithelial ovarian cancer has peritoneal metastases and ascites. What is the management?&nbsp;</span>(INICET NOV 2023)</p>",
      "unique_key": "Q1393497",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585262,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Debulking followed by chemotherapy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For advanced ovarian cancer with peritoneal metastases and ascites, the preferred treatment is surgical debulking followed by chemotherapy. This approach helps reduce tumor load and enhances chemotherapy effectiveness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Debulking followed by radiotherapy:</strong> Radiotherapy is not typically used as a first-line treatment in ovarian cancer with peritoneal metastases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Chemotherapy followed by debulking:</strong> Starting with chemotherapy may be considered, but debulking first is usually preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Staging laparotomy:</strong> Staging laparotomy is primarily diagnostic, not therapeutic.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In advanced epithelial ovarian cancer with peritoneal involvement, initial surgical debulking followed by chemotherapy is the standard management approach to maximize treatment efficacy.</span></p>",
      "correct_choice_id": 175688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47853,
      "choices": [
        {
          "id": 191007,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat ultrasound at 32 weeks</span></p>"
        },
        {
          "id": 191008,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeat ultrasound at 39 weeks</span></p>"
        },
        {
          "id": 191009,
          "text": "<p><span style=\"font-size:12.0pt;\">Elective LSCS at 39 weeks</span></p>"
        },
        {
          "id": 191010,
          "text": "<p><span style=\"font-size:12.0pt;\">Allow for a normal delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12 weeks pregnant lady visited the doctor. On ultrasound, it was found she has a low-lying placenta. What is the next best step?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q4522711",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585265,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Repeat ultrasound at 32 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">At 12 weeks gestation, the presence of a low-lying placenta is often not a cause for immediate concern because the placenta typically \"migrates\" upward as the pregnancy progresses. This migration is due to the expansion of the uterus, which effectively moves the placenta away from the cervix. Therefore, the recommended management is to repeat an ultrasound between 28 to 32 weeks to reassess the position of the placenta. By this time, the majority of placentas that were initially low-lying will have moved to a safer position, allowing for a more accurate determination of whether there will be any complications related to placenta previa.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The next best step for a pregnant woman found to have a low-lying placenta at 12 weeks is to repeat the ultrasound at around 32 weeks to reassess the placenta's position and determine appropriate management.</span></p>",
      "correct_choice_id": 191007,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5872,
      "choices": [
        {
          "id": 23458,
          "text": "<p><span style=\"font-size:12pt;\">Immediate C- section</span></p>"
        },
        {
          "id": 23459,
          "text": "<p><span style=\"font-size:12pt;\">Dexamethasone for fetal lung maturity</span></p>"
        },
        {
          "id": 23460,
          "text": "<p><span style=\"font-size:12pt;\">Induction - vaginal delivery</span></p>"
        },
        {
          "id": 23461,
          "text": "<p><span style=\"font-size:12pt;\">MgSO4 IV</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 33-week multigravida woman presents with epigastric pain, headache, visual symptoms, proteinuria: 3+. The next step of management would be?&nbsp;</span>(INICET NOV 2019)</p>",
      "unique_key": "Q6448978",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585268,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) MgSO4 IV</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In the scenario of imminent eclampsia, neuro-prophylaxis with Magnesium Sulfate (MgSO4) is recommended. Imminent eclampsia is characterized by symptoms such as severe headaches, visual disturbances, epigastric pain, and hyperreflexia, indicating that the woman is at high risk of developing seizures (eclampsia). MgSO4 is effective in preventing seizures in women with severe pre-eclampsia and imminent eclampsia, as supported by the Magpie Trial, which is the largest comparative study demonstrating its efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Magpie Trial (MgSO4 for Prevention of Eclampsia) showed that MgSO4 prophylaxis in women with severe pre-eclampsia effectively prevented the development of eclampsia, making it the standard of care for neuro-prophylaxis in such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Dexamethasone:</strong> Dexamethasone is an antenatal steroid used to enhance fetal lung maturation in pregnancies less than 34+6 weeks. It is administered in doses of 6 mg every 12 hours for a total of four doses. However, it is not used for neuro-prophylaxis in imminent eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Betamethasone:</strong> Betamethasone, like dexamethasone, is also an antenatal steroid given to enhance fetal lung maturation in pregnancies less than 34+6 weeks. The typical regimen is 12 mg administered 24 hours apart for two doses. It is not used for neuro-prophylaxis in imminent eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. LSCS:</strong> The mode of delivery, whether vaginal or Lower Segment Cesarean Section (LSCS), will depend on the status of the cervical os and other obstetric indications. LSCS is not a prophylactic measure for preventing eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">MgSO4 is recommended for neuro-prophylaxis in women with severe or imminent eclampsia to prevent seizures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg 1840</strong></span></p>",
      "correct_choice_id": 23461,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5743,
      "choices": [
        {
          "id": 22944,
          "text": "<p><span style=\"font-size:12.0pt;\">Thicken the cervical mucus</span></p>"
        },
        {
          "id": 22945,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevents ovulation</span></p>"
        },
        {
          "id": 22946,
          "text": "<p><span style=\"font-size:12.0pt;\">Kills the sperms in the cervical canal</span></p>"
        },
        {
          "id": 22947,
          "text": "<p><span style=\"font-size:12.0pt;\">Inhibits penetration of sperm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not the mechanism of action of progesterone only pills?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q3770785",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585267,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Kills the sperms in the cervical canal</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Progesterone only pills (POPs), also known as mini pills, act through several mechanisms to prevent pregnancy, but they do not kill sperms in the cervical canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Incorrect. Progesterone only pills do not have a spermicidal effect. They do not kill sperm; instead, they work by altering the cervical mucus and preventing ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mechanisms of action include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Thickening the cervical mucus</strong>: This makes it difficult for sperm to enter the uterus and fertilize an egg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Preventing ovulation</strong>: Although not as consistently as combined oral contraceptives, POPs can inhibit ovulation in some women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Inhibiting penetration of sperm</strong>: By thickening the cervical mucus and affecting the endometrial lining, POPs inhibit the sperm’s ability to penetrate and fertilize an egg.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Progesterone only pills prevent pregnancy by thickening cervical mucus, inhibiting ovulation, and preventing sperm penetration, but they do not kill sperm in the cervical canal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 323, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22946,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6077,
      "choices": [
        {
          "id": 24277,
          "text": "<p><span style=\"font-size:12pt;\">11-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 24278,
          "text": "<p><span style=\"font-size:12pt;\">14-year-old girl with Tanner stage 1 breasts</span></p>"
        },
        {
          "id": 24279,
          "text": "<p><span style=\"font-size:12pt;\">13-year-old girl with Tanner stage 5 breasts</span></p>"
        },
        {
          "id": 24280,
          "text": "<p><span style=\"font-size:12pt;\">12-year-old with Tanner stage 4 breasts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following patients would be classified as having primary amenorrhea?</span>&nbsp;(INICET NOV 2022)</p>",
      "unique_key": "Q6263330",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585250,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 14-year-old girl with Tanner stage 1 breasts</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Primary amenorrhea</strong> is defined as:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">No menstruation by age 13 in the absence of secondary sexual characteristics.</span></li><li><span style=\"font-size:12pt;\">No menstruation by age 15 in the presence of secondary sexual characteristics.</span></li></ul></li><li><span style=\"font-size:12pt;\">In this context:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>Option A</strong>: An 11-year-old girl with Tanner stage 1 breasts would not be classified as having primary amenorrhea since she is not yet 13.</span></li><li><span style=\"font-size:12pt;\"><strong>Option B</strong>: A 14-year-old girl with Tanner stage 1 breasts meets the criteria for primary amenorrhea because she is older than 13 and has no secondary sexual characteristics (Tanner stage 1 breasts).</span></li><li><span style=\"font-size:12pt;\"><strong>Option C</strong>: A 13-year-old girl with Tanner stage 5 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li><li><span style=\"font-size:12pt;\"><strong>Option D</strong>: A 12-year-old with Tanner stage 4 breasts is developing normally and does not meet the criteria for primary amenorrhea.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 11-year-old girl with Tanner stage 1 breasts</strong>: The girl is too young to be classified as having primary amenorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 13-year-old girl with Tanner stage 5 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 12-year-old with Tanner stage 4 breasts</strong>: The girl has developed secondary sexual characteristics and is within the normal age range for the onset of menstruation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Primary amenorrhea is defined as the absence of menstruation by age 13 without secondary sexual characteristics or by age 15 with secondary sexual characteristics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: ACOG Committee opinion menstruation in girls and adolescents (2015), Speroff’s gynecologic endocrinology 7th edition pg401, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 450</strong></span></p>",
      "correct_choice_id": 24278,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44008,
      "choices": [
        {
          "id": 175691,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brenner tumor</span></span></span></p>"
        },
        {
          "id": 175692,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arrhenoblastoma</span></span></span></p>"
        },
        {
          "id": 175693,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoid tumor of the ovary</span></span></span></p>"
        },
        {
          "id": 175694,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Theca cell tumor</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is a virilizing ovarian tumor?&nbsp;</span></span>(INICET NOV 2023)</p>",
      "unique_key": "Q7036757",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585263,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Arrhenoblastoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arrhenoblastoma, also known as Sertoli-Leydig cell tumor, is a virilizing ovarian tumor that can produce androgens leading to masculinization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Brenner tumor:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Brenner tumors are epithelial ovarian cancer</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Carcinoid tumor of the ovary:&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carcinoid tumors is a germ cell tumor, primarily produce serotonin and do not typically cause virilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Theca cell tumor:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Theca cell tumors are sex xord tumours and can produce estrogen, not androgens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arrhenoblastoma is a virilizing ovarian tumor known for its androgen production, often leading to masculinizing symptoms in females.</span></span></span></p>",
      "correct_choice_id": 175692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5901,
      "choices": [
        {
          "id": 23574,
          "text": "<p><span style=\"font-size:12pt;\">Serum progesterone on day 14</span></p>"
        },
        {
          "id": 23575,
          "text": "<p><span style=\"font-size:12pt;\">Serum progesterone on day 21</span></p>"
        },
        {
          "id": 23576,
          "text": "<p><span style=\"font-size:12pt;\">Serum LH on day 14</span></p>"
        },
        {
          "id": 23577,
          "text": "<p><span style=\"font-size:12pt;\">Serum LH on day 21</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman visits an infertility clinic. She has a regular 28-day cycle. How should she be evaluated?&nbsp;</span>(INICET NOV 2020)</p>",
      "unique_key": "Q2951263",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585227,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Serum progesterone on day 21</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For a woman with a regular 28-day cycle, serum progesterone is typically measured on day 21 to assess for ovulation. Progesterone levels on day 21 of the menstrual cycle provide information about whether ovulation has occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Day 21 Progesterone Measurement:</strong> In a regular 28-day cycle, day 21 corresponds to the mid-luteal phase, about 7 days after ovulation. Progesterone levels peak during this time, and values above 10 ng/mL are indicative of ovulation.</span></li><li><span style=\"font-size:12pt;\"><strong>Purpose:</strong> This test helps to determine if the cycles are ovulatory or anovulatory.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other tests for ovulation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Basal body temperature:</strong> A biphasic temperature pattern suggests ovulation.</span></li><li><span style=\"font-size:12pt;\"><strong>Urinary LH kits (ovulation prediction kits):</strong> Ovulation occurs the day following the peak LH surge.</span></li><li><span style=\"font-size:12pt;\"><strong>Endometrial biopsy:</strong> This can provide histological confirmation of ovulation.</span></li><li><span style=\"font-size:12pt;\"><strong>Ultrasonography:</strong> Follicular tracking can visualize the growth and rupture of the follicle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Serum progesterone on day 14:</strong> Measuring progesterone on day 14 is not useful as it corresponds to the follicular phase when progesterone levels are low and not indicative of ovulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Serum LH on day 14:</strong> While an LH surge around day 14 can indicate impending ovulation, it does not confirm that ovulation has actually occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Serum LH on day 21:</strong> Measuring LH on day 21 is not useful for assessing ovulation, as LH levels peak around mid-cycle and are not elevated during the luteal phase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For a woman with a regular 28-day menstrual cycle, measuring serum progesterone on day 21 is the appropriate method to evaluate for ovulation, with levels above 10 ng/mL indicating that ovulation has occurred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Textbook of gynecology 3<sup>rd</sup> edition Pg435</strong></span></p>",
      "correct_choice_id": 23575,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47852,
      "choices": [
        {
          "id": 191003,
          "text": "<p><span style=\"font-size:12.0pt;\">Reassure and continue the packet</span></p>"
        },
        {
          "id": 191004,
          "text": "<p><span style=\"font-size:12.0pt;\">Take 2 pills the same day and continue</span></p>"
        },
        {
          "id": 191005,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue pills and take extra precaution for 1 week</span></p>"
        },
        {
          "id": 191006,
          "text": "<p><span style=\"font-size:12.0pt;\">Start a new packet immediately</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 23y woman who is using the combined oral contraceptive pill misses 2 pills in the 3rd week of the pack. What is the next best step?&nbsp;(FMGE JANUARY 2024)</span></p>",
      "unique_key": "Q8233660",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585264,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Take 2 pills the same day and continue</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">According to the Ministry of Health and Family Welfare, the missed pill guidelines are –</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/07/screenshot-2024-06-07-122802.png\" alt=\"\" width=\"1000\" height=\"479\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Reassure and continue the packet:&nbsp;</strong>Simply continuing the packet without taking the missed pills would increase the risk of pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Continue pills and take extra precaution for 1 week:&nbsp;</strong>This option is more applicable for missing three or more pills, where additional precautions and possibly emergency contraception might be necessary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Start a new packet immediately:&nbsp;</strong>This approach is necessary only when three or more pills are missed in the third week, to avoid a pill-free interval and ensure continued contraceptive protection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">If one or two combined oral contraceptive pills are missed in the third week, the woman should take the last missed pill as soon as possible, then continue the pack as scheduled, taking two pills in one day if necessary. This minimizes the risk of pregnancy.</span></p>",
      "correct_choice_id": 191004,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5740,
      "choices": [
        {
          "id": 22932,
          "text": "<p><span style=\"font-size:12.0pt;\">Development of cardiac failure within 5 months of delivery</span></p>"
        },
        {
          "id": 22933,
          "text": "<p><span style=\"font-size:12.0pt;\">Left ventricular diastolic dysfunction</span></p>"
        },
        {
          "id": 22934,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of identifiable cause</span></p>"
        },
        {
          "id": 22935,
          "text": "<p><span style=\"font-size:12.0pt;\">Dilated left ventricle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are true regarding peripartum cardiomyopathy except?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q6685117",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585266,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Left ventricular diastolic dysfunction</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripartum cardiomyopathy (PPCM) is a form of heart failure<strong> that occurs during the last month of pregnancy or within five months postpartum</strong>. It is characterized by left ventricular systolic dysfunction, rather than diastolic dysfunction. The diagnostic criteria for PPCM include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Cardiac failure developing in the last month of pregnancy or within five months after delivery.</span></li><li><span style=\"font-size:12.0pt;\">Absence of an identifiable cause for the cardiac failure.</span></li><li><span style=\"font-size:12.0pt;\">Absence of recognizable heart disease prior to the last month of pregnancy.</span></li><li><span style=\"font-size:12.0pt;\">Echocardiographic evidence of left ventricular systolic dysfunction (ejection fraction &lt;45% or fractional shortening &lt;30%) along with a dilated left ventricle.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Development of cardiac failure within 5 months of delivery</strong>: Correct. PPCM develops within five months of delivery.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Absence of identifiable cause</strong>: Correct. PPCM is diagnosed in the absence of an identifiable cause for cardiac failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Dilated left ventricle</strong>: Correct. PPCM is associated with a dilated left ventricle.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Peripartum cardiomyopathy is characterized by left ventricular systolic dysfunction and occurs within the last month of pregnancy or up to five months postpartum, in the absence of an identifiable cause for cardiac failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: https://www.ncbi.nlm.nih.gov/books/NBK482185/</strong></span></p>",
      "correct_choice_id": 22933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5682,
      "choices": [
        {
          "id": 22700,
          "text": "<p><span style=\"font-size:12pt;\">Low LH and FSH</span></p>"
        },
        {
          "id": 22701,
          "text": "<p><span style=\"font-size:12pt;\">Low testosterone</span></p>"
        },
        {
          "id": 22702,
          "text": "<p><span style=\"font-size:12pt;\">Oligospermia</span></p>"
        },
        {
          "id": 22703,
          "text": "<p><span style=\"font-size:12pt;\">Low prolactin levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple with 2 children who are not able to conceive for over an year now present to the OPD. The male partner is diagnosed to be having hypogonadotrophic hypogonadism. Which of the following is not true?&nbsp;(INICET MAY 2017)</span></p>",
      "unique_key": "Q2041323",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585242,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Low prolactin levels</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Hypogonadotropic hypogonadism in males is characterized by a deficiency of gonadotropins (LH and FSH), which leads to low testosterone levels and impaired spermatogenesis. This condition often results in oligospermia or azoospermia, contributing to infertility. Additionally, hypogonadotropic hypogonadism is frequently associated with hyperprolactinemia rather than low prolactin levels.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Low LH and FSH:</strong> Hypogonadotropic hypogonadism is marked by low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) due to inadequate secretion from the pituitary gland.</span></li><li><span style=\"font-size:12pt;\"><strong>Low testosterone:</strong> The low levels of LH lead to reduced stimulation of Leydig cells in the testes, resulting in low testosterone levels.</span></li><li><span style=\"font-size:12pt;\"><strong>Oligospermia:</strong> The low levels of FSH result in impaired spermatogenesis, often leading to oligospermia or azoospermia.</span></li><li><span style=\"font-size:12pt;\"><strong>Low prolactin levels (Incorrect):</strong> Hypogonadotropic hypogonadism is associated with hyperprolactinemia, not low prolactin levels. Elevated prolactin can inhibit the secretion of gonadotropins, further exacerbating the condition.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Low LH and FSH:</strong> True. Gonadotropin deficiency is a hallmark of hypogonadotropic hypogonadism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Low testosterone:</strong> True. The deficiency in LH leads to low testosterone production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Oligospermia:</strong> True. The deficiency in FSH leads to impaired spermatogenesis, causing oligospermia or azoospermia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">A male with hypogonadotropic hypogonadism will have high prolactin levels, low gonadotropins (LH and FSH), low testosterone, and often oligospermia or azoospermia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 199, DC Dutta’s Textbook of Gynecology 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 22703,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5982,
      "choices": [
        {
          "id": 23898,
          "text": "<p><span style=\"font-size:12pt;\">Pap smear</span></p>"
        },
        {
          "id": 23899,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Hysteroscopy</span></p>"
        },
        {
          "id": 23900,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Biopsy</span></p>"
        },
        {
          "id": 23901,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Dilatation and curettage</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">The following set of instruments are used for which procedure?</span>&nbsp;(INICET NOV 2021)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2021-1.jpg\" alt=\"\" width=\"300\" height=\"236\"></p>",
      "unique_key": "Q4199335",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585260,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Pap smear</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The given set of instruments are commonly used for taking a Pap smear. The instruments include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Cusco's bivalved self-retaining speculum:</strong> Used to visualize the cervix.</span></li><li><span style=\"font-size:12pt;\"><strong>Koplin's jar:</strong> Used to store the collected sample.</span></li><li><span style=\"font-size:12pt;\"><strong>Slides to prepare the smear:</strong> Used for placing the collected sample.</span></li><li><span style=\"font-size:12pt;\"><strong>Ayer's spatula and endocervical brush:</strong> Used to collect cells from the ectocervix and endocervix, respectively.</span></li><li><span style=\"font-size:12pt;\"><strong>Fixative containing 95% ethanol:</strong> Used to preserve the collected sample on the slides.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysteroscopy:</strong> This procedure involves using a hysteroscope to visualize the inside of the uterine cavity, and the instruments shown are not used for this purpose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Biopsy:</strong> While some of these instruments might be used in a cervical biopsy, the specific combination shown is typically for a Pap smear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Dilatation and curettage:</strong> This procedure involves dilating the cervix and scraping the endometrial lining, which requires different instruments than those shown.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The set of instruments shown, including Cusco's speculum, Koplin's jar, slides, Ayer's spatula, endocervical brush, and fixative, are used for performing a Pap smear to collect and preserve cervical cell samples for cytological examination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of gynecology 6<sup>th</sup> edition Pg 110,111, William’s textbook of gynecology 3<sup>rd</sup> edition 632, 633</strong></span></p>",
      "correct_choice_id": 23898,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5816,
      "choices": [
        {
          "id": 23234,
          "text": "<p><span style=\"font-size:12pt;\">Radical vulvectomy with unilateral LN dissection</span></p>"
        },
        {
          "id": 23235,
          "text": "<p><span style=\"font-size:12pt;\">Radical vulvectomy with bilateral LN dissection</span></p>"
        },
        {
          "id": 23236,
          "text": "<p><span style=\"font-size:12pt;\">Simple vulvectomy</span></p>"
        },
        {
          "id": 23237,
          "text": "<p><span style=\"font-size:12pt;\">Chemoradiation with resection</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 76-year-old female presented with a non-healing ulcer on the labia majora for a period of 6 months, measuring 2 cm x 3 cm. No lymph nodes were palpable. Biopsy shows squamous cell carcinoma. How do you manage this case?&nbsp;</span>(INICET NOV 2018)</p>",
      "unique_key": "Q2514297",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585246,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Radical vulvectomy with bilateral LN dissection</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">This patient has a midline lesion on the labia majora, which indicates that the lesion is close to or crossing the midline. In cases of midline lesions or lesions within 2 cm of the midline, bilateral inguinofemoral lymph node dissection is necessary along with radical vulvectomy. This approach ensures that all potential pathways of lymphatic spread are adequately addressed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>New (2021) FIGO staging for carcinoma of the vulva:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Tumors 2 cm or less in size with 1 mm or less invasion:</strong> Treated by wide local excision.</span></li><li><span style=\"font-size:12pt;\"><strong>Tumors more than 2 cm with more than 1 mm depth of invasion:</strong> Treated by modified radical vulvectomy with groin lymph node dissection.</span></li><li><span style=\"font-size:12pt;\"><strong>LN dissection through separate incision:</strong> Lymph node dissection should be inguino-femoral.</span></li><li><span style=\"font-size:12pt;\"><strong>Bilateral lymph node dissection:</strong> Performed for midline lesions and those within 2 cm of the midline.</span></li><li><span style=\"font-size:12pt;\"><strong>Unilateral dissection:</strong> If the lesion is unilateral and ipsilateral nodes are negative, bilateral dissection is not necessary.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Radical vulvectomy with unilateral LN dissection:</strong> This would be appropriate for unilateral lesions with no evidence of contralateral spread, but not for midline lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Simple vulvectomy:</strong> Simple vulvectomy is not sufficient for managing invasive squamous cell carcinoma with a lesion size of 2 cm x 3 cm and potential for deeper invasion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Chemoradiation with resection:</strong> Chemoradiation followed by resection is typically reserved for advanced or inoperable cases, or where there is a need to downstage the tumor before surgery. This case can be managed surgically given the size and lack of palpable lymph nodes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For midline lesions or lesions within 2 cm of the midline in squamous cell carcinoma of the vulva, radical vulvectomy with bilateral inguinofemoral lymph node dissection is the appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: FIGO staging of CA vulva, Berek and Novak’s gynecology 15<sup>th</sup> edition pg 1436, William’s textbook of gynecology 3rd edition pg 484-485.</strong></span></p>",
      "correct_choice_id": 23235,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5937,
      "choices": [
        {
          "id": 23718,
          "text": "<p><span style=\"font-size:12pt;\">30 mg</span></p>"
        },
        {
          "id": 23719,
          "text": "<p><span style=\"font-size:12pt;\">300 mg</span></p>"
        },
        {
          "id": 23720,
          "text": "<p><span style=\"font-size:12pt;\">60 mg</span></p>"
        },
        {
          "id": 23721,
          "text": "<p><span style=\"font-size:12pt;\">600 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">What is the dose of Ulipristal used in emergency contraception?&nbsp;</span><span style=\"font-size:12.0pt;\">(NEET PG &nbsp;2019)</span></p>",
      "unique_key": "Q6726107",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585241,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 30 mg</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The dose of Ulipristal in emergency contraception is 30 mg to be taken within 72 hrs (can be taken upto 120hrs).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The following can be used as emergency contraceptives:</span></p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-76.jpg\" alt=\"\" width=\"900\" height=\"317\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The dose of Ulipristal for emergency contraception is 30 mg, to be taken within 72 hours (up to 120 hours) after unprotected intercourse.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 630, DC Dutta’s Textbook of Gynecology, 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5926,
      "choices": [
        {
          "id": 23674,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pap smear</span></span></span></p>"
        },
        {
          "id": 23675,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Visual inspection with iodine</span></span></span></p>"
        },
        {
          "id": 23676,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colposcopy</span></span></span></p>"
        },
        {
          "id": 23677,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 62-year-old patient with a history of diabetes and hypertension came with post-menopausal bleeding. Which of the following you will do to evaluate the cause?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q2798438",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585236,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Endometrial sampling</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling is done to evaluate a patient presenting with postmenopausal bleeding.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Transvaginal ultrasound (TVS) is a better first-line investigation since TVS is not included in the options, endometrial sampling is the next best answer.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Both diabetes and hypertension are risk factors for endometrial hyperplasia and carcinoma hence endometrial sampling would be the more appropriate test as compared to tests for cervical cancer screening.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling is indicated in a woman with post-menopausal bleeding with the endometrial thickness is &gt; 4 mm. </span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pap smear</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A pap smear should be done in all women complaining of post menopausal women with a normal looking cervix and a cervical biopsy for all women with a cervical growth but in this question, based on risk factors, we are more worried about endometrial cancer and hence endometrial sampling is a better option. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Visual inspection with iodine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is not the preferred option and even if cervical cancer screening is warranted, a pap smear or HPV is better. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Colposcopy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is indicated if there is any cytological abnormality on the pap smear</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endometrial sampling is done to evaluate a patient presenting with postmenopausal bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Page no 560, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition.</span></strong></span></span></p>",
      "correct_choice_id": 23677,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54774,
      "choices": [
        {
          "id": 218561,
          "text": "<p><span style=\"font-size:12.0pt;\">Gonadal dysgenesis</span></p>"
        },
        {
          "id": 218562,
          "text": "<p><span style=\"font-size:12.0pt;\">Mullerian agenesis</span></p>"
        },
        {
          "id": 218563,
          "text": "<p><span style=\"font-size:12.0pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 218564,
          "text": "<p><span style=\"font-size:12.0pt;\">Androgen insensitivity syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old girl with primary amenorrhea presents to the OPD. She has Tanner stage IV secondary sexual characters. Her karyotype is 46XX. FSH is 5 and LH is 13. What is the likely diagnosis? (INICET MAY 2024)</span></p>",
      "unique_key": "Q6885804",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585272,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Mullerian agenesis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient presents with primary amenorrhea, Tanner stage IV secondary sexual characteristics, a 46XX karyotype, and normal gonadotropin levels (FSH and LH). The development of secondary sexual characteristics indicates that the hypothalamic-pituitary-ovarian (HPO) axis is functioning properly, which usually suggests normal ovarian function. Mullerian agenesis (also known as Mayer-Rokitansky-Küster-Hauser syndrome) is a condition where the uterus and part of the vaginal canal are absent, but ovarian function and secondary sexual characteristics remain normal. This condition commonly presents with primary amenorrhea in individuals with a 46XX karyotype.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Gonadal dysgenesis</strong>: Gonadal dysgenesis refers to underdeveloped or non-functional gonads, leading to low estrogen levels and subsequent lack of secondary sexual characteristics. In this case, FSH and LH levels would typically be elevated, not normal.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Kallmann syndrome</strong>: Kallmann syndrome is characterized by a lack of secondary sexual development due to low levels of gonadotropins (FSH and LH). This condition usually presents with delayed or absent puberty, unlike the normal Tanner stage IV development seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Androgen insensitivity syndrome (AIS)</strong>: AIS involves individuals with a 46XY karyotype who are phenotypically female due to the body's inability to respond to androgens. This patient has a 46XX karyotype, ruling out AIS as a possible diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mullerian agenesis is a likely diagnosis in a patient with primary amenorrhea, normal secondary sexual development, normal FSH/LH levels, and a 46XX karyotype.</span></p>",
      "correct_choice_id": 218562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47239,
      "choices": [
        {
          "id": 188567,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta previa</span></p>"
        },
        {
          "id": 188568,
          "text": "<p><span style=\"font-size:12.0pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 188569,
          "text": "<p><span style=\"font-size:12.0pt;\">Show</span></p>"
        },
        {
          "id": 188570,
          "text": "<p><span style=\"font-size:12.0pt;\">Rupture uterus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25 yr G2P1 presents with heavy bleeding at 32 weeks. On examination, there is hypotension. The abdomen is tender and fetal parts not palpable. What is the probable diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q5027288",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585223,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Abruptio placenta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In the case of a 25-year-old G2P1 woman presenting with heavy bleeding at 32 weeks of gestation, several key clinical features point towards a diagnosis of abruptio placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Abruptio placenta, or placental abruption, is a condition where the placenta detaches from the uterine wall prematurely, leading to significant bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The critical signs here are:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Hypotension</strong>: This indicates significant blood loss, which can be seen in both placenta previa and placental abruption.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tender abdomen</strong>: The tenderness of the abdomen is a hallmark of placental abruption due to the irritation and inflammation caused by the bleeding and the detached placenta.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fetal parts not palpable</strong>: This is due to the tense and tender uterus, which is characteristic of placental abruption.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Abruptio placenta - Immediate management (delivery) is crucial to prevent maternal and fetal complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, placenta previa typically presents with painless bleeding, and the uterus is usually relaxed and non-tender. Placenta previa involves the placenta covering the cervical os, which can lead to painless bleeding without the tenderness seen in placental abruption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Placenta previa</strong>: Usually presents with painless bleeding and a relaxed, non-tender uterus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Show</strong>: Refers to the passage of a small amount of blood or mucus plug as labor begins, which does not cause significant bleeding or abdominal tenderness.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rupture uterus</strong>: While it can cause significant bleeding and abdominal tenderness, it is less common and typically associated with a history of uterine surgery or trauma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Bleeding in Pregnancy after 28 weeks à is due to APH</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">2 MC causes are of APH are – Placenta Previa (Painless bleeding, nontender uterus) and Abruptio placenta (Painful bleeding, tense &amp; tender uterus)</span></p>",
      "correct_choice_id": 188568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47312,
      "choices": [
        {
          "id": 188859,
          "text": "<p><span style=\"font-size:12.0pt;\">Pituitary disorder</span></p>"
        },
        {
          "id": 188860,
          "text": "<p><span style=\"font-size:12.0pt;\">Ovarian disorder</span></p>"
        },
        {
          "id": 188861,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine disorder</span></p>"
        },
        {
          "id": 188862,
          "text": "<p><span style=\"font-size:12.0pt;\">Adrenal disorder</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents with amenorrhea and a history of frequent abortions. FSH is 7. hCG is &lt; 5. What is the cause of amenorrhea?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q9463240",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585256,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C) Uterine disorder</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient has normal FSH and hCG levels, indicating that the hypothalamus, pituitary, and ovarian functions are intact.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>- FSH levels less than 10 are considered normal, and an hCG level of less than 5 indicates that the patient is not pregnant.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these normal hormonal profiles, the issue is likely not with the endocrine function but with the uterus itself. One possible uterine disorder that can cause amenorrhea is <strong>Asherman syndrome,</strong> which involves intrauterine adhesions (synechiae). This condition can follow frequent uterine procedures such as dilation and curettage (D&amp;C) or infections, leading to a history of frequent abortions and subsequent amenorrhea due to scarring within the uterine cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pituitary disorder</strong>: This would typically result in abnormal levels of FSH and LH due to issues with the hypothalamic-pituitary axis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ovarian disorder</strong>: If the ovaries were not functioning properly, FSH levels would likely be elevated as the body tries to stimulate the ovaries.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Adrenal disorder</strong>: These disorders do not typically present with the specific combination of symptoms and normal hormonal profile seen in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A normal hormonal profile with amenorrhea and a history of frequent abortions suggests a uterine disorder, such as Asherman syndrome, where intrauterine adhesions disrupt the normal menstrual cycle.</span></p>",
      "correct_choice_id": 188861,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5940,
      "choices": [
        {
          "id": 23730,
          "text": "<p><span style=\"font-size:12pt;\">6-8 weeks</span></p>"
        },
        {
          "id": 23731,
          "text": "<p><span style=\"font-size:12pt;\">11-14 weeks</span></p>"
        },
        {
          "id": 23732,
          "text": "<p><span style=\"font-size:12pt;\">14-16 weeks</span></p>"
        },
        {
          "id": 23733,
          "text": "<p><span style=\"font-size:12pt;\">16-20 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the ideal time for nuchal translucency evaluation? (NEET PG 2019)</span></p>",
      "unique_key": "Q1069719",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585244,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 11-14 weeks</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Nuchal Translucency (NT):</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Definition:</strong> Nuchal translucency refers to the maximum thickness of the subcutaneous translucent area between the skin and soft tissue overlying the fetal spine at the back of the neck.</span></li><li><span style=\"font-size:12pt;\"><strong>Significance:</strong> An increased NT measurement is associated with an increased risk for fetal aneuploidy (such as Down syndrome) and various structural anomalies including cardiovascular defects, hydrops fetalis, and cystic hygroma.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Timing:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">NT is measured between <strong>11 weeks</strong> and <strong>13 weeks 6 days</strong> (or <strong>11-14 weeks</strong>) of gestation. This time frame is critical as it ensures the accuracy of the measurement and its correlation with potential anomalies.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Measurement Criteria:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Crown-Rump Length (CRL):</strong> Should be between 45-84 mm.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal Position:</strong> Fetus should be in the mid-sagittal plane and in a neutral position.</span></li><li><span style=\"font-size:12pt;\"><strong>Image Quality:</strong> The image must be magnified, and the widest space should be measured.</span></li><li><span style=\"font-size:12pt;\"><strong>Caliper Placement:</strong> The ‘+’ calipers must be placed on the inner borders of the nuchal space, ensuring the amnion is seen separately.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Screening Efficiency:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>NT Alone:</strong> Provides a 65% detection rate for Down syndrome.</span></li><li><span style=\"font-size:12pt;\"><strong>Combined Test:</strong> When combined with the Dual Marker test (beta hCG and PAPP-A), the detection rate for Down syndrome improves to 80%.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. 6-8 weeks:</strong> This is too early for accurate NT measurement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. 14-16 weeks:</strong> This is beyond the optimal time frame for NT evaluation, reducing the effectiveness of the screening.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. 16-20 weeks:</strong> This period is too late for NT measurement, which should be performed in the first trimester.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The ideal time for nuchal translucency evaluation is between 11-14 weeks of gestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-77.jpg\" alt=\"\" width=\"300\" height=\"241\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 860, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23731,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "CriteriaBased",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21770,
      "choices": [
        {
          "id": 87044,
          "text": "<p><span style=\"font-size:12pt;\">Serum uric acid levels</span></p>"
        },
        {
          "id": 87045,
          "text": "<p><span style=\"font-size:12pt;\">Liver Function tests</span></p>"
        },
        {
          "id": 87046,
          "text": "<p><span style=\"font-size:12pt;\">Complete blood count</span></p>"
        },
        {
          "id": 87047,
          "text": "<p><span style=\"font-size:12pt;\">Urine dipstick</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A nulliparous woman presented with 26 weeks of gestation for routine antenatal check-up. Her blood pressure was 150/90 mmHg. What can be the next best step?&nbsp;</span>(FMGE JANUARY 2023)</p>",
      "unique_key": "Q4106847",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585224,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Urine dipstick</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">A pregnant woman with BP &gt; 140/90 mmHg after 20 weeks of gestation should be evaluated for gestational hypertension or Pre-eclampsia.</span></li><li><span style=\"font-size:12pt;\">So, the next step should be looking out for proteinuria by Urine dipstick test.&nbsp; (Here Proteinuria refers to urine dipstick greater than or equal to +2 (1 gm/L) on at least two random clean catch samples &nbsp;&nbsp;or a &nbsp;total 24 hour urine protein &gt; 0.3 gm)</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/28/screenshot-2023-09-28-191550.jpg\" alt=\"\" width=\"1000\" height=\"422\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Serum Uric Acid</strong>: Blood changes in pre-eclampsia may not be very specific however a serum Uric acid of more than 4.5 mg/dl may be considered as a biochemical marker</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Liver Function tests&nbsp;</strong>and<strong> Option C. Complete blood count</strong>: LFTs may be raised and there may altered coagulation profile and thrombocytopenia</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In pregnant women with BP &gt; 140/90 mmHg after 20 weeks of gestation, the next best step is to evaluate for proteinuria using a urine dipstick test to screen for pre-eclampsia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of Obstetrics page 256, 262</strong></span></p>",
      "correct_choice_id": 87047,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55312,
      "choices": [
        {
          "id": 220709,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 220710,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        },
        {
          "id": 220711,
          "text": "<p><span style=\"font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 220712,
          "text": "<p><span style=\"font-size:12.0pt;\">12-15</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The ideal number of ANC visits is: (FMGE JULY 2024)</span></p>",
      "unique_key": "Q2682310",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585228,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;D) 12-15</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Antenatal care (ANC) visits are crucial for monitoring the health of both the mother and the fetus during pregnancy. Different guidelines recommend varying numbers of visits:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Ministry of Health and Family Welfare (India):</strong> Recommends at least 4 visits.</span></li><li><span style=\"font-size:12.0pt;\"><strong>World Health Organization (WHO):</strong> Suggests 8 visits, referring to them as \"contacts.\"</span></li><li><span style=\"font-size:12.0pt;\"><strong>American guidelines and practical recommendations:</strong> Advise 12-15 visits, ensuring comprehensive care.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ideal number of ANC visits, according to American guidelines and actual practice, is 12-15. This schedule is designed to closely monitor the pregnancy and promptly address any complications:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Monthly visits until 28 weeks of gestation.</span></li><li><span style=\"font-size:12.0pt;\">Bi-weekly visits from 28 to 36 weeks.</span></li><li><span style=\"font-size:12.0pt;\">Weekly visits from 36 weeks until delivery.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This frequency allows for timely detection and management of potential issues, ensuring the best outcomes for both mother and baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The ideal number of ANC visits is 12-15, as recommended by American guidelines, to ensure comprehensive prenatal care.</span></p>",
      "correct_choice_id": 220712,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6008,
      "choices": [
        {
          "id": 24002,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2, 3, 4 and 5</span></span></span></p>"
        },
        {
          "id": 24003,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 2 and 5</span></span></span></p>"
        },
        {
          "id": 24004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2, 3, 4 and 5</span></span></span></p>"
        },
        {
          "id": 24005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1, 3 and 5</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A couple already has 3 children and has been trying for another one for the last 1 year. However, the husband is diagnosed with hypogonadotropic hypogonadism. Which of the following is/are true?&nbsp;</span></span></span>(INICET MAY 2022)</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low FSH, low LH</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High FSH, low LH</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Oligospermia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low prolactin</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Low testosterone</span></span></span></li>\r\n</ol>",
      "unique_key": "Q7270098",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585274,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 1, 3 and 5 </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypogonadotropic hypogonadism is a condition where there is decreased production of gonadotropins (FSH and LH) by the pituitary gland, leading to decreased stimulation of the testes and consequent reduced production of sex hormones such as testosterone. This results in:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Low FSH, low LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> In hypogonadotropic hypogonadism, both follicle-stimulating hormone (FSH) and luteinizing hormone (LH) are low due to inadequate stimulation from the pituitary gland.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. Oligospermia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Reduced levels of FSH and LH lead to decreased stimulation of the testes, which can result in reduced sperm production and oligospermia (low sperm count).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">5. Low testosterone:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypogonadotropic hypogonadism leads to reduced levels of testosterone because the testes are not adequately stimulated by FSH and LH.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The following are not true for hypogonadotropic hypogonadism:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. High FSH, low LH:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This pattern is more characteristic of hypergonadotropic hypogonadism (primary testicular failure) rather than hypogonadotropic hypogonadism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. Low prolactin:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Hypogonadotropic hypogonadism is typically associated with normal or high levels of prolactin if there is an underlying pituitary issue. Low prolactin is not a characteristic feature of hypogonadotropic hypogonadism.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In hypogonadotropic hypogonadism, both FSH and LH levels are low, testosterone levels are low, and oligospermia is often present.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 232, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5899,
      "choices": [
        {
          "id": 23566,
          "text": "<p><span style=\"font-size:12pt;\">Abruptio placenta</span></p>"
        },
        {
          "id": 23567,
          "text": "<p><span style=\"font-size:12pt;\">Placenta previa</span></p>"
        },
        {
          "id": 23568,
          "text": "<p><span style=\"font-size:12pt;\">Hydramnios</span></p>"
        },
        {
          "id": 23569,
          "text": "<p><span style=\"font-size:12pt;\">Preterm labour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A hypertensive pregnant woman with abdominal pain, bleeding per vaginum, and loss of fetal movements. What is the probable diagnosis?&nbsp;</span>(INICET NOV 2020)</p>",
      "unique_key": "Q7329645",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585225,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Abruptio placenta</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Abruptio placentae, also known as placental abruption, commonly occurs in hypertensive disorders of pregnancy. It is characterized by the premature separation of the placenta from the uterus, leading to painful vaginal bleeding, abdominal pain, and often fetal distress or fetal death. The uterus may be tonically contracted in such cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Key Points:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hypertensive Disorders:</strong> Abruptio placentae is frequently associated with hypertensive disorders of pregnancy.</span></li><li><span style=\"font-size:12pt;\"><strong>Clinical Presentation:</strong> Painful vaginal bleeding, abdominal pain, and loss of fetal movements are hallmark signs.</span></li><li><span style=\"font-size:12pt;\"><strong>Uterine Contraction:</strong> The uterus may feel firm and tender, indicating a tonic contraction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Placenta previa:</strong> Placenta previa involves painless vaginal bleeding due to the placenta covering the cervix. It generally does not cause decreased fetal movements unless there is severe bleeding leading to maternal and fetal compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Hydramnios:</strong> Hydramnios (polyhydramnios) involves excessive amniotic fluid and does not typically present with bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Preterm labor:</strong> Preterm labor typically does not present with bleeding and is characterized by regular uterine contractions leading to cervical changes before 37 weeks of gestation. Prematurity in preterm labor is iatrogenic if induced.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Abruptio placenta should be suspected in a hypertensive pregnant woman presenting with painful vaginal bleeding, abdominal pain, and loss of fetal movements, as it is commonly associated with hypertensive disorders and presents with these clinical features.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Textbook of obstetrics 26<sup>th</sup> edition pg 1944</strong></span></p>",
      "correct_choice_id": 23566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5797,
      "choices": [
        {
          "id": 23159,
          "text": "<p><span style=\"font-size:12pt;\">Uterotonic within 1 minute of delivery</span></p>"
        },
        {
          "id": 23160,
          "text": "<p><span style=\"font-size:12pt;\">Delayed clamping, cutting and ligation of cord</span></p>"
        },
        {
          "id": 23161,
          "text": "<p><span style=\"font-size:12pt;\">Gentle massage of uterus</span></p>"
        },
        {
          "id": 23162,
          "text": "<p><span style=\"font-size:12pt;\">Controlled cord traction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in the active management of the third stage of labor to prevent post-partum hemorrhage?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q9399000",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585235,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Gentle massage of uterus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>AMTSL</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Purpose</strong>: To prevent <strong>postpartum hemorrhage (PPH)</strong>, a major cause of maternal death.</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:16px;\"><strong>Give a uterotonic drug</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>Oxytocin 10 IU IM</strong> immediately after the birth of the baby</span></li><li><span style=\"font-size:16px;\">This helps the uterus contract and reduce bleeding</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Controlled Cord Traction (CCT)</strong></span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Gently pull the umbilical cord while supporting the uterus to help deliver the placenta</span></li><li><span style=\"font-size:16px;\">Only if trained and placenta is ready to come</span></li></ul></li><li><span style=\"font-size:16px;\"><strong>Intermittent uterine tone assessment</strong></span></li></ol><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Delayed cord clamping</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">Wait 1–3 minutes before clamping the umbilical cord</span></li><li><span style=\"font-size:16px;\">Improves baby’s iron stores and reduces anemia</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Uterotonic within 1 minute of delivery:</strong> This is a critical step in AMTSL to prevent PPH by promoting uterine contractions.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Delayed clamping, cutting and ligation of cord:</strong> Delayed cord clamping (after 1 to 3 minutes) is recommended for all births to enhance neonatal outcomes</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option D. Controlled cord traction:</strong> This is a part of AMTSL to aid in the delivery of the placenta.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The active management of the third stage of labor includes the administration of a uterotonic, controlled cord traction, and assessing uterine tone rather than sustained uterine massage for all women who have received a uterotonic.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Ref:&nbsp;</strong></span><a href=\"https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1\"><span style=\"font-size:16px;\"><strong><u>https://iris.who.int/bitstream/handle/10665/120082/WHO_RHR_14.20_eng.pdf?sequence=1</u></strong></span></a></p>",
      "correct_choice_id": 23161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5683,
      "choices": [
        {
          "id": 22704,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></span></span></p>"
        },
        {
          "id": 22705,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 19, 23, 33, 45, 58</span></span></span></p>"
        },
        {
          "id": 22706,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></span></span></p>"
        },
        {
          "id": 22707,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV Nonavalent vaccine is active against which of the following serotypes?&nbsp;(INICET MAY 2017)</span></span></p>",
      "unique_key": "Q9810511",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585243,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HPV Vaccines available are</span></span></span>:</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervarix (Bivalent): 16, 18</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18, 31, 33, 45, 52, 58.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cervavac (India&rsquo;s indigenous HPV vaccine): Quadrivalent: 6, 11, 16, 18</span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gardasil 9 is a nonavalent HPV vaccine effective against 9 serotypes of the virus </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">These include: 6, 11, 16, 18, 31, 33, 45, 52, 58.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref:&nbsp;</span></strong><a href=\"https://www.merckvaccines.com/gardasil9/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">https://www.merckvaccines.com/gardasil9/</span></strong></a></span></span></p>",
      "correct_choice_id": 22707,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5742,
      "choices": [
        {
          "id": 22940,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Conisation</span></span></span></p>"
        },
        {
          "id": 22941,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cryotherapy</span></span></span></p>"
        },
        {
          "id": 22942,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Targeted biopsy</span></span></span></p>"
        },
        {
          "id": 22943,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pap smear</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 40-year-old woman comes with a history of postcoital bleeding and a visible mass seen in cervix per speculum. The next step to be done?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q1181897",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585269,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Targeted biopsy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A targeted biopsy (punch biopsy) is the next line of management in the above case as the patient is symptomatic (postcoital bleeding) and has a visible lesion. This approach allows for the direct sampling of the lesion to assess for malignancy or other pathological changes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Conisation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Conisation is an excisional procedure that is typically performed once biopsy-proven cervical intraepithelial neoplasia (CIN 2 and 3) is diagnosed. It is not the initial step for a visible mass with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Cryotherapy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Cryotherapy is an ablative procedure used for treating CIN1 or 2. It is not suitable for initial diagnosis or for lesions suspected of being malignant.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Pap smear:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A Pap smear is done when there are symptoms with no identifiable lesion. It is a screening tool and not diagnostic for a visible lesion with postcoital bleeding.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a symptomatic patient with a visible cervical lesion and postcoital bleeding, a targeted biopsy is the appropriate next step to obtain a definitive diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 327, DC Dutta&rsquo;a Textbook of gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22942,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6041,
      "choices": [
        {
          "id": 24134,
          "text": "<p><span style=\"font-size:12pt;\">Hospitalize, send urine and blood cultures and start on antibiotics.</span></p>"
        },
        {
          "id": 24135,
          "text": "<p><span style=\"font-size:12pt;\">Oral antibiotics once afebrile</span></p>"
        },
        {
          "id": 24136,
          "text": "<p><span style=\"font-size:12pt;\">Maintain urine output &gt; 50 ml/h; Intravenous crystalloids can be given</span></p>"
        },
        {
          "id": 24137,
          "text": "<p><span style=\"font-size:12pt;\">Discharge if afebrile for 72 h; Continue antibiotics for 5 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant lady at 20 weeks of gestation comes with complaints of acute onset fever, and pain in the right lumbar region. It is associated with chills, nausea, and vomiting. Urinalysis reveals the presence of E. coli and a diagnosis of acute pyelonephritis is made. Which of the following is incorrect regarding the management of acute pyelonephritis in pregnancy?&nbsp;</span>(INICET MAY 2022)</p>",
      "unique_key": "Q6934510",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585232,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Discharge if afebrile for 72 h; Continue antibiotics for 5 days</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The management of acute pyelonephritis during pregnancy involves several key steps to ensure effective treatment and prevent complications:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Hospitalization:</strong> Necessary for intravenous antibiotics and monitoring.</span></li><li><span style=\"font-size:12pt;\"><strong>Urine and Blood Cultures:</strong> Essential for identifying the pathogen and tailoring antibiotic therapy.</span></li><li><span style=\"font-size:12pt;\"><strong>Intravenous Crystalloids:</strong> Used to maintain adequate urine output (≥50 mL/h) and ensure proper hydration.</span></li><li><span style=\"font-size:12pt;\"><strong>Antibiotics:</strong> Initially given intravenously, with the switch to oral antibiotics once the patient is afebrile.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The incorrect statement is <strong>Option D</strong>. The correct management protocol dictates:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Discharge Criteria:&nbsp;The patient can be discharged once afebrile for 24 hours, not 72 hours.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Duration of Antibiotics:&nbsp;The recommended course of antibiotics is 7 to 10 days, not just 5 days.</strong></span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hospitalize, send urine and blood cultures and start on antibiotics:</strong> Correct. Hospitalization, urine and blood cultures, and starting antibiotics are all appropriate steps in managing acute pyelonephritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>Oral antibiotics once afebrile:</strong> Correct. Switching to oral antibiotics is appropriate once the patient is afebrile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Maintain urine output &gt; 50 ml/h; Intravenous crystalloids can be given:</strong> Correct. Maintaining a urine output of &gt; 50 mL/h and using intravenous crystalloids are standard practices to manage hydration and ensure adequate renal function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Discharge from the hospital should be considered once the patient is afebrile for 24 hours, and antibiotics should be continued for 7 to 10 days in cases of acute pyelonephritis in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 2594, Williams Obstetrics, 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5961,
      "choices": [
        {
          "id": 23814,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Overflow incontinence</span></span></span></p>"
        },
        {
          "id": 23815,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Urge incontinence</span></span></span></p>"
        },
        {
          "id": 23816,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress incontinence</span></span></span></p>"
        },
        {
          "id": 23817,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neurogenic bladder</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 56-year-old multipara woman presented with grade II/III uterine prolapse with cystocele. She complains of passing urine on coughing and sneezing. What is the type of urinary incontinence seen in this patient?</span></span>&nbsp;(NEET PG 2021)</p>",
      "unique_key": "Q4266109",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585253,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Stress incontinence </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress urinary incontinence is characterized by the involuntary leakage of urine due to increased intra-abdominal pressure, such as during coughing, sneezing, or physical exertion. It is commonly seen in women with utero-vaginal prolapse, where the support structures of the pelvic floor are weakened, leading to bladder dysfunction.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Overflow incontinence:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Overflow incontinence occurs when the bladder cannot empty properly, leading to frequent or constant dribbling of urine. It is usually secondary to an obstruction, such as an enlarged prostate in men or severe prolapse in women causing a kink in the urethra. This condition does not typically present with leakage during activities that increase intra-abdominal pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Urge incontinence:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Urge incontinence is the involuntary leakage of urine accompanied by or immediately preceded by a sudden, intense urge to urinate. This type of incontinence can be due to overactive bladder syndrome, where there is involuntary contraction of the bladder muscles.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Neurogenic bladder:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Neurogenic bladder refers to a dysfunction of the urinary bladder due to a central or peripheral nervous system pathology. This can result in various types of incontinence, including both overflow and urge incontinence, depending on the nature of the neurological impairment.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Stress urinary incontinence is characterized by involuntary leakage of urine due to increased intra-abdominal pressure and is commonly seen in women with utero-vaginal prolapse.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 597, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23816,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5905,
      "choices": [
        {
          "id": 23590,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pelvic tumor</span></span></span></p>"
        },
        {
          "id": 23591,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Herpes infection</span></span></span></p>"
        },
        {
          "id": 23592,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Heart disease</span></span></span></p>"
        },
        {
          "id": 23593,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">History of lower transverse cesarean section in last two pregnancies</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is not a contraindication for the induction of labor?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2019)</span></span></p>",
      "unique_key": "Q9930307",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585229,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Heart disease</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiovascular diseases are not a contraindication for vaginal delivery. In fact, NVD is preferred in heart disease patients. The second stage of labour is cut short with the use of instrumental vaginal delivery like forceps or ventouse assisted vaginal delivery. </span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Pelvic tumor</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Pelvic tumor if diagnosed may interfere with normal labor and needs to be evaluated before deciding the mode of delivery</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Herpes infection</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:&nbsp; Active herpes is an absolute contra-indication to a normal delivery due to the high viral shedding in the lesions and increased risk of neonatal herpes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. History of lower transverse cesarean section in last two pregnancies</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: History of 2 or more previous cesareans is also a contra-indication to a vaginal delivery and hence induction is not done</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiovascular diseases are not a contraindication for vaginal delivery, and NVD is preferred in heart disease patients.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 332, Dc Dutta&rsquo;s Textbook of Obstetrics 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23592,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20485,
      "choices": [
        {
          "id": 81902,
          "text": "<p><span style=\"font-size:12pt;\">Prolonged recovery time</span></p>"
        },
        {
          "id": 81903,
          "text": "<p><span style=\"font-size:12pt;\">Not knowing the extent of thermal burns</span></p>"
        },
        {
          "id": 81904,
          "text": "<p><span style=\"font-size:12pt;\">Increased bleeding</span></p>"
        },
        {
          "id": 81905,
          "text": "<p><span style=\"font-size:12pt;\">Increased pain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman is planned for a laparoscopic hysterectomy. She asks the surgeon for any disadvantages of this procedure. What is the disadvantage of laparoscopic over open surgery? (NEET PG 2023)</span></p>",
      "unique_key": "Q2117708",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585220,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Not knowing the extent of thermal burns</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Laparoscopic hysterectomy is a minimally invasive procedure that offers numerous benefits compared to open surgery. However, one significant disadvantage is the difficulty in assessing the extent of thermal burns. Thermal burns can occur due to the use of electrosurgical instruments, and the limited visual field in laparoscopic surgery can make it challenging to identify and evaluate the full extent of these burns. This limitation is crucial because undetected thermal injury can lead to postoperative complications.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Prolonged recovery time:</strong> Laparoscopic surgery typically results in a shorter recovery time compared to open surgery. The minimally invasive nature of the procedure means less tissue damage and faster healing.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Increased bleeding:</strong> Laparoscopic surgery generally involves less blood loss than open surgery. The precision of the instruments and the smaller incisions contribute to reduced bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Increased pain:</strong> One of the advantages of laparoscopic surgery is less postoperative pain. The smaller incisions and less invasive approach result in decreased pain and discomfort for the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The disadvantage of laparoscopic over open surgery is not knowing the extent of thermal burns.</span></p>",
      "correct_choice_id": 81903,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6118,
      "choices": [
        {
          "id": 24441,
          "text": "<p><span style=\"font-size:12pt;\">Immature teratoma</span></p>"
        },
        {
          "id": 24442,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Mature cystic teratoma</span></p>"
        },
        {
          "id": 24443,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Mucinous cystadenoma</span></p>"
        },
        {
          "id": 24444,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Serous cystadenoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A surgically resected specimen of an ovarian mass is shown below. What is the likely diagnosis?&nbsp;</span>(INICET NOV 2022)</p><p style=\"text-align:justify;\">&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xUY8Y7x.jpg\" alt=\"\" width=\"300\" height=\"363\"></span></p>",
      "unique_key": "Q1298522",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585261,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Mature cystic teratoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The specimen shows an ovarian mass with a tuft of hair in a cystic space, which is characteristic of a mature cystic teratoma. Key points about mature cystic teratomas include:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Teratomas are germ cell tumors</strong>: They contain various types of tissues derived from the three germ layers: ectoderm, mesoderm, and endoderm.</span></li><li><span style=\"font-size:12pt;\"><strong>Mature cystic teratomas (dermoid cysts)</strong>: Typically unilocular and contain sebaceous material, hair, and sometimes other tissues such as teeth, bone, cartilage, thyroid tissue, and neural tissues.</span></li><li><span style=\"font-size:12pt;\"><strong>Presentation</strong>: Most patients are asymptomatic, but they may present with an abdominal mass, acute pain due to torsion of the ovary, or rarely due to rupture of the cyst.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment</strong>: Laparoscopic ovarian cystectomy is the treatment of choice for mature teratomas.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Immature teratoma</strong>: These are malignant and contain immature embryonic tissues, often neuroectodermal. They usually occur in younger patients and are more aggressive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Mucinous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains mucinous material and does not contain hair or other tissues.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Serous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains clear serous fluid and lacks the complex tissues found in teratomas.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Mature cystic teratomas (dermoid cysts) are characterized by the presence of multiple tissue types such as hair, sebaceous material, and sometimes teeth or bone within a cystic ovarian mass.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg, Dutta’s textbook of gynecology 6 th edition pg</strong></span></p>",
      "correct_choice_id": 24442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5981,
      "choices": [
        {
          "id": 23894,
          "text": "<p><span style=\"font-size:12pt;\">Inhibin B</span></p>"
        },
        {
          "id": 23895,
          "text": "<p><span style=\"font-size:12pt;\">Unconjugated Estriol (E3)</span></p>"
        },
        {
          "id": 23896,
          "text": "<p><span style=\"font-size:12pt;\">AFP</span></p>"
        },
        {
          "id": 23897,
          "text": "<p><span style=\"font-size:12pt;\">hCG</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not included in the quadruple screening test?&nbsp;</span>(INICET NOV 2021)</p>",
      "unique_key": "Q1234441",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585258,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Inhibin B</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The triple and Quadruple test are done between 15 – 21 weeks.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Components of Triple test are: Free β hCG, unconjugated Estriol (uE3) and Maternal Serum α-fetoprotein.</span></li><li><span style=\"font-size:12pt;\">Components of the Quadruple test are: Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein. And Inhibin A.</span></li></ul><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/30/untitled-279.jpg\" alt=\"\" width=\"900\" height=\"274\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">*Easy to remember: <strong>B</strong> for <strong>B</strong>ig; so in Down’s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The quadruple screening test includes Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein (AFP), and Inhibin A. Inhibin B is not included in the quadruple test.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23894,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47309,
      "choices": [
        {
          "id": 188847,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum blues</span></p>"
        },
        {
          "id": 188848,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum depression</span></p>"
        },
        {
          "id": 188849,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum anxiety</span></p>"
        },
        {
          "id": 188850,
          "text": "<p><span style=\"font-size:12.0pt;\">Postpartum psychosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">At the 5th postnatal day, a woman presents with sadness, irritability, restlessness, and reduced sleep. What is the diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q6949769",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585254,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Postpartum blues</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postpartum blues, also known as \"baby blues,\" typically occur within the first few days after delivery and can last up to two weeks. It is characterized by mood swings, sadness, irritability, restlessness, and difficulty sleeping. These symptoms are usually mild and self-limiting, resolving on their own with support and reassurance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Postpartum depression</strong>: This condition occurs after the first two weeks post-delivery and can persist for months. It includes <strong>more severe symptoms</strong> such as persistent sadness, lack of interest in the baby, feelings of hopelessness, and possibly suicidal thoughts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Postpartum anxiety</strong>: This condition involves excessive worry, anxiety, and often includes physical symptoms like <strong>palpitations or hyperventilation</strong>. It can occur at any time during the postpartum period.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Postpartum psychosis</strong>: This is a rare but <strong>severe condition</strong> that usually occurs within the first few weeks after delivery. It involves symptoms such as hallucinations, delusions, severe agitation, and risk of harm to the mother or baby.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postpartum blues are common in the first few days after delivery and are characterized by sadness, irritability, restlessness, and reduced sleep. The condition is generally mild and self-limiting, resolving with support and care.</span></p>",
      "correct_choice_id": 188847,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 56835,
      "choices": [
        {
          "id": 226733,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Knee jerk presen</span></span></span></p>"
        },
        {
          "id": 226734,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">RR 18/min</span></span></span></p>"
        },
        {
          "id": 226735,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Visual disturbance</span></span></span></p>"
        },
        {
          "id": 226736,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Urine output 60ml in 4hr</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 23-year-old woman with eclampsia is on a maintenance dose of MgSO₄. When will you stop MgSO₄? (NEET PG 2024)</span></span></span></p>",
      "unique_key": "Q2732293",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585218,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Urine output 60ml in 4hr</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Magnesium sulfate (MgSO₄) is used in eclampsia management to prevent seizures. However, MgSO₄ toxicity can occur, which necessitates stopping or adjusting the dose. The first sign of MgSO₄ toxicity is the absence of deep tendon reflexes (DTRs), followed by respiratory depression and reduced urine output. Since magnesium is excreted through the kidneys, urine output is a critical measure of magnesium toxicity risk. A urine output of <strong>less than 30 ml per hour</strong> (or 60 ml in 4 hours) indicates poor excretion and potential toxicity, requiring immediate adjustment or cessation of MgSO₄.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Knee jerk present:</span></strong><span style=\"font-size:12.0pt\"> The presence of a knee jerk (deep tendon reflex) is a positive sign and indicates that magnesium levels are not yet toxic. The absence of DTRs is the first indication of toxicity, so this is not a reason to stop MgSO₄.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. RR 18/min:</span></strong><span style=\"font-size:12.0pt\"> A respiratory rate above 10 breaths per minute is safe when on MgSO₄. Respiratory depression is a sign of advanced toxicity; therefore, a rate of 18 per minute is not concerning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Visual disturbances:</span></strong><span style=\"font-size:12.0pt\"> Visual disturbances are symptoms associated with eclampsia or pre-eclampsia (e.g., retinal detachment or blurred vision) but are not signs of MgSO₄ toxicity. These do not indicate the need to stop MgSO₄.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">MgSO₄ should be stopped if the patient&rsquo;s urine output is less than 30 ml per hour (or 60 ml in 4 hours), as this indicates poor excretion and risk of magnesium toxicity.</span></span></span></p>",
      "correct_choice_id": 226736,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6061,
      "choices": [
        {
          "id": 24214,
          "text": "<p><span style=\"font-size:12pt;\">Menstruation</span></p>"
        },
        {
          "id": 24215,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Trophoblastic disease</span></p>"
        },
        {
          "id": 24216,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Immediately after delivery</span></p>"
        },
        {
          "id": 24217,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Ruptured condom during intercourse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is an absolute contraindication for the insertion of the device shown in the image below?</span><span style=\"color:black;font-size:12.0pt;\">&nbsp;</span>(NEET PG 2022)</p><p>&nbsp;</p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/untitled-80.jpg\" alt=\"\" width=\"200\" height=\"304\"></span></p>",
      "unique_key": "Q4608616",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585240,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Trophoblastic disease</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">The given image shows a copper-containing IUCD (intrauterine contraceptive device).</span></li><li><span style=\"font-size:12pt;\">ABSOLUTE c/I to an Intra-uterine device are:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Unexplained uterine or vaginal bleeding</span></li><li><span style=\"font-size:12pt;\">Post abortal sepsis/ Puerperal sepsis/ Current Pelvic inflammatory/ disease, Genital Tuberculosis</span></li><li><span style=\"font-size:12pt;\">Cancers: Endometrial cancer, Cervical cancer, Gestational trophoblastic neoplasia</span></li><li><span style=\"font-size:12pt;\">Large fibroid distorting the uterine cavity, Mullerian anomalies distorting the uterine cavity</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Menstruation</strong>: Intra-uterine device can be inserted even during periods although preferably it should be inserted post-menstrual</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Immediately after delivery</strong>: This is called as Post placental IUCD insertion (within 10 mins of placental delivery)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Ruptured condom during intercourse</strong>: Following a ruptured condom, CUT can be inserted as an emergency contraception</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Trophoblastic disease is an&nbsp;</strong>ABSOLUTE c/I to an Intra-uterine device.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.who.int/publications/i/item/9789241549158\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/publications/i/item/9789241549158</u></strong></span></a></p>",
      "correct_choice_id": 24215,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 47243,
      "choices": [
        {
          "id": 188583,
          "text": "<p><span style=\"font-size:12.0pt;\">Uretero-vaginal fistula</span></p>"
        },
        {
          "id": 188584,
          "text": "<p><span style=\"font-size:12.0pt;\">Vesico-vaginal fistula</span></p>"
        },
        {
          "id": 188585,
          "text": "<p><span style=\"font-size:12.0pt;\">Utero-vaginal fistula</span></p>"
        },
        {
          "id": 188586,
          "text": "<p><span style=\"font-size:12.0pt;\">Urethro-vaginal fistula</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is being evaluated for urinary incontinence following a hysterectomy. In the 3-swab test, the middle swab is stained with dye. What is the diagnosis?&nbsp;</span>(FMGE JULY 2023)</p>",
      "unique_key": "Q2886060",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585226,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Vesico-vaginal fistula</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The 3-swab test is used to diagnose the presence and location of a fistula between the urinary tract and the genital tract following a hysterectomy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/04/screenshot-2024-06-04-170136.png\" alt=\"\" width=\"600\" height=\"474\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3-swab Test:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Three dry swabs</strong> are placed in the vagina:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Swab 1: Upper vagina</span></li><li><span style=\"font-size:12.0pt;\">Swab 2: Middle vagina</span></li><li><span style=\"font-size:12.0pt;\">Swab 3: Lower vagina</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Methylene blue dye</strong> is then injected into the bladder through a urinary catheter.</span></li><li><span style=\"font-size:12.0pt;\">After waiting for 5-10 minutes, the swabs are removed and examined for staining and wetness:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">If the <strong>upper swab</strong> is wet but not stained with dye, it suggests a <strong>uretero-vaginal fistula</strong> since urine from the ureter is leaking into the vagina without dye.</span></li><li><span style=\"font-size:12.0pt;\">If the <strong>middle swab</strong> is wet and stained with blue dye, it indicates a <strong>vesico-vaginal fistula</strong> because the dye from the bladder is leaking directly into the vagina through the fistula.</span></li><li><span style=\"font-size:12.0pt;\">If the <strong>lower swab</strong> is stained and wet, it indicates a <strong>urethro-vaginal fistula</strong>.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In this case, the middle swab being stained with dye indicates that the fistula is between the bladder (vesica) and the vagina, confirming a vesico-vaginal fistula.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Uretero-vaginal fistula</strong>: The upper swab would be wet but not stained with dye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Utero-vaginal fistula</strong>: This is not relevant post-hysterectomy as the uterus has been removed.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urethro-vaginal fistula</strong>: The lower swab would be stained and wet.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A positive 3-swab test with the middle swab stained with dye indicates a vesico-vaginal fistula, which is a common complication following a hysterectomy where the bladder and vagina are abnormally connected.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>– the best IOC in this case is – CT Urography</span></p>",
      "correct_choice_id": 188584,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "FMGE",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5852,
      "choices": [
        {
          "id": 23378,
          "text": "<p><span style=\"font-size:12pt;\">Deceleration</span></p>"
        },
        {
          "id": 23379,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Acceleration</span></p>"
        },
        {
          "id": 23380,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Normal</span></p>"
        },
        {
          "id": 23381,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Deceleration followed by acceleration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does this Cardio-Tocography show?&nbsp;</span>&nbsp;(INICET MAY 2019)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_LB2EmwO.jpg\" alt=\"\" width=\"300\" height=\"204\"></span></p>",
      "unique_key": "Q3801571",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585257,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Deceleration</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Cardio-Tocography (CTG) in question shows decelerations, which are characterized by a drop in the fetal heart rate (FHR) by at least 15 beats per minute (bpm) lasting for at least 15 seconds.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Types of Decelerations on CTG:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Early Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The nadir (lowest point) of the deceleration corresponds with the peak of the uterine contraction.</span></li><li><span style=\"font-size:12pt;\">Caused by head compression during contractions.</span></li><li><span style=\"font-size:12pt;\">Commonly observed in the second stage of labor.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Late Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">The nadir of the deceleration occurs after the peak of the contraction.</span></li><li><span style=\"font-size:12pt;\">Indicative of uteroplacental insufficiency, which can lead to fetal distress or hypoxia.</span></li><li><span style=\"font-size:12pt;\">Considered an ominous sign and requires prompt evaluation and intervention.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Variable Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">There is no fixed relationship between the deceleration and uterine contractions.</span></li><li><span style=\"font-size:12pt;\">Caused by umbilical cord compression, often seen with oligohydramnios.</span></li><li><span style=\"font-size:12pt;\">Significant if persistent, with FHR &lt;70 bpm for more than 60 seconds.</span></li></ul></li><li><span style=\"font-size:12pt;\"><strong>Prolonged Deceleration:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Occurs when the deceleration lasts beyond 2 minutes but less than 10 minutes.</span></li><li><span style=\"font-size:12pt;\">May indicate acute fetal hypoxia, such as with cord prolapse or intrapartum abruption.</span></li></ul></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Acceleration:</strong> This would show an increase in the fetal heart rate by at least 15 bpm lasting for at least 15 seconds, which is not the case here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Normal:</strong> A normal CTG would not show any decelerations or would show a typical pattern of fetal heart rate variability and accelerations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Deceleration followed by acceleration:</strong> This pattern would indicate a combination of deceleration and acceleration, which is not specified here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Decelerations on a Cardio-Tocography indicate a decrease in fetal heart rate by at least 15 bpm lasting for at least 15 seconds, with different types signifying various conditions and levels of concern.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 994, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23378,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5904,
      "choices": [
        {
          "id": 23586,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory rate</span></span></span></p>"
        },
        {
          "id": 23587,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vital capacity</span></span></span></p>"
        },
        {
          "id": 23588,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional residual capacity</span></span></span></p>"
        },
        {
          "id": 23589,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inspiratory capacity</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following decreases in pregnancy?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(NEET PG 2019)</p>",
      "unique_key": "Q8058852",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585230,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Functional residual capacity </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional residual capacity (FRC) is the volume of air remaining in the lungs at the end of a normal expiration. During pregnancy, the diaphragm is elevated due to the enlarging uterus, leading to a decrease in FRC by approximately 22%. This is primarily due to reductions in expiratory reserve volume and residual volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Respiratory rate</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The respiratory rate typically remains unchanged during pregnancy, staying at about 14-16 breaths per minute.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Vital capacity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Vital capacity, which is the sum of inspiratory reserve volume, tidal volume, and expiratory reserve volume, remains unchanged during pregnancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Inspiratory capacity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Inspiratory capacity increases during pregnancy by about 10%. This increase is due to the higher tidal volume and inspiratory reserve volume.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional residual capacity decreases during pregnancy due to the elevation of the diaphragm caused by the enlarging uterus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Functional residual capacity decreases in pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/14/untitled-71.jpg\" style=\"height:826px; width:1000px\" /></span></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 189, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23588,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6042,
      "choices": [
        {
          "id": 24138,
          "text": "<p><span style=\"font-size:18px;\">4 contractions in 20 min and 8 contractions in 60 min with changes in cervix</span></p>"
        },
        {
          "id": 24139,
          "text": "<p><span style=\"font-size:18px;\">Cervical dilatation &gt; 2 cm</span></p>"
        },
        {
          "id": 24140,
          "text": "<p><span style=\"font-size:18px;\">More than 80 percent effaced cervix</span></p>"
        },
        {
          "id": 24141,
          "text": "<p><span style=\"font-size:18px;\">Cervix posterior in position</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">All of the following are the diagnostic criteria for preterm labor except?</span></p>",
      "unique_key": "Q2472082",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585233,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Cervix posterior in position</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">Preterm labor (PTL) is labor that occurs before the 37th week of gestation. Accurate diagnosis involves evaluating several key criteria:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:18px;\"><strong>Contractions:</strong> At least one regular contraction every 10 minutes, or 4 contractions in 20 minutes, or 8 contractions in 60 minutes, with or without pain.</span></li><li><span style=\"font-size:18px;\"><strong>Cervical Changes:</strong> Cervical dilation greater than 2 cm and more than 80% effacement are significant indicators of preterm labor.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:18px;\">The incorrect statement is <strong>Option D</strong>. A cervix that is posterior in position is not a diagnostic criterion for preterm labor. Instead, the cervix's position may be less relevant than its dilation and effacement in the diagnosis of preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option A. 4 contractions in 20 min and 8 contractions in 60 min with changes in cervix:</strong> Correct. Regular contractions that meet the criteria of 4 in 20 minutes or 8 in 60 minutes, along with changes in the cervix, are used to diagnose preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option B. Cervical dilatation &gt; 2 cm:</strong> Correct. Cervical dilation greater than 2 cm is a diagnostic criterion for preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Option C. More than 80 percent effaced cervix:</strong> Correct. Cervical effacement greater than 80% is another diagnostic criterion for preterm labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\">The cervix being in a posterior position is not a diagnostic criterion for preterm labor. The diagnosis involves assessing contraction patterns and cervical changes such as dilation and effacement.</span></p><p>&nbsp;</p><p><span style=\"font-size:18px;\"><strong>Ref: Page no 366, DC Dutta’s Textbook of Obstetrics, 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 24141,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "DiagnosisBased",
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6076,
      "choices": [
        {
          "id": 24273,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of knee jerk</span></span></span></p>"
        },
        {
          "id": 24274,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypotension</span></span></span></p>"
        },
        {
          "id": 24275,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression</span></span></span></p>"
        },
        {
          "id": 24276,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reduced muscle tone</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with eclampsia is started on magnesium sulfate. What is the first sign of magnesium sulfate toxicity?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;</span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q4909687",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585249,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Loss of knee jerk</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Therapeutic range</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The therapeutic range of magnesium for the prevention of seizures in eclampsia is 4-7 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of Deep Tendon Reflexes (DTRs)</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: The first sign of magnesium sulfate toxicity is the loss of DTRs, specifically the knee jerk reflex. This occurs when plasma magnesium levels reach 7-10 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Respiratory depression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: When plasma magnesium levels reach 10-12 mEq/L, respiratory depression occurs. Beyond 12 mEq/L, respiratory paralysis and respiratory arrest can occur.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cardiac arrest</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Cardiac arrest can happen if serum magnesium levels exceed 25 mEq/L.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitoring</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: A patient on magnesium sulfate is monitored for toxicity by checking clinical signs, including DTRs, urine output, and respiratory rate.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment of toxicity</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Treatment for magnesium sulfate toxicity involves administering calcium gluconate or calcium chloride (1g intravenously) and discontinuing magnesium sulfate, which usually reverses mild to moderate respiratory depression.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Hypotension</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Hypotension is not the first sign of magnesium sulfate toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Respiratory depression</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Respiratory depression occurs at higher magnesium levels (10-12 mEq/L), after the loss of knee jerk reflex.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Reduced muscle tone</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Reduced muscle tone is not the first sign of magnesium sulfate toxicity and is less specific than the loss of DTRs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The first sign of magnesium sulfate toxicity is the loss of deep tendon reflexes (knee jerk).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 24<sup>th</sup> edition page 759</span></strong></span></span></p>",
      "correct_choice_id": 24273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5664,
      "choices": [
        {
          "id": 22628,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART immediately and continue till 6 weeks after delivery</span></span></span></span></p>"
        },
        {
          "id": 22629,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART after 1st trimester and continue life-long</span></span></span></span></p>"
        },
        {
          "id": 22630,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART immediately and continue life-long</span></span></span></span></p>"
        },
        {
          "id": 22631,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART after 1st trimester and continue till 6 weeks after delivery</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman is diagnosed to be positive for HIV in her first trimester. What is the most appropriate management?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(NEET PG 2018)</span></span></p>",
      "unique_key": "Q1605584",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585234,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Start ART immediately and continue life long </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The National AIDS Control Organisation (NACO) recommends that all pregnant women with HIV should start antiretroviral therapy (ART) immediately, regardless of the stage of their disease or their CD4 count. This approach is aimed at reducing the viral load as quickly as possible, thereby decreasing the risk of mother-to-child transmission of HIV. ART should be continued lifelong to ensure ongoing viral suppression and the health of the mother.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management of HIV-positive pregnancy includes:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Antenatal care:</span></span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Testing for other sexually transmitted diseases (STDs), CMV, toxoplasmosis, tuberculosis, fungal, and other opportunistic infections.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Partner/husband should also be tested.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To prevent pneumocystis pneumonia, start co-trimoxazole if CD4 count is &le; 250 cells/mm&sup3; and continue through pregnancy, delivery, and breastfeeding (dose: double strength tablet, 1 tablet daily).</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Assess immunization status and update as needed.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Counseling on the impact of HIV on pregnancy and factors influencing the progression of the disease and risk of perinatal transmission.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CD4 count testing in each trimester.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Monitor HIV RNA levels monthly after changing/initiating therapy.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CBC, LFT, and KFT in each trimester.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Anti-retroviral therapy for all:</span></span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As per NACO: Start ART at diagnosis (regardless of CD4 count); continue lifelong.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Initiate lifelong ART in all pregnant women with confirmed HIV infection regardless of WHO clinical stage or CD4 cell count.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">TDF + 3TC + EFV is recommended as first-line ART in pregnant and breastfeeding women (including pregnant women in the first trimester of pregnancy).</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pregnant women detected to be HIV-positive for the first time in labor should be initiated on ART (TDF + 3TC + EFV) immediately.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Start ART immediately upon diagnosis of HIV in pregnancy and continue lifelong to reduce the risk of mother-to-child transmission and maintain the health of the mother.</span></span></span></span></p>",
      "correct_choice_id": 22630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5854,
      "choices": [
        {
          "id": 23386,
          "text": "<p><span style=\"font-size:12pt;\">Gardasil</span></p>"
        },
        {
          "id": 23387,
          "text": "<p><span style=\"font-size:12pt;\">Biovac</span></p>"
        },
        {
          "id": 23388,
          "text": "<p><span style=\"font-size:12pt;\">Rabivac</span></p>"
        },
        {
          "id": 23389,
          "text": "<p><span style=\"font-size:12pt;\">Tvac</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old unmarried female has come to the gynae OPD for cervical cancer vaccination. Which is preferred?</span>&nbsp;(INICET MAY 2019)</p>",
      "unique_key": "Q3408412",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585259,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Gardasil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for cervical cancer prevention. It is a quadrivalent HPV vaccine that provides protection against four serotypes of the Human Papillomavirus (HPV): 6, 11, 16, and 18.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>HPV Serotypes Covered by Gardasil:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\"><strong>6 and 11:</strong> These types are associated with anogenital warts.</span></li><li><span style=\"font-size:12pt;\"><strong>16 and 18:</strong> These types are linked to cervical cancer and other HPV-related cancers.</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is administered as an intramuscular injection with a recommended schedule of three doses (0, 2, and 6 months).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Available HPV Vaccines:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\"><strong>Cervarix (Bivalent):</strong> Covers HPV serotypes 16 and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil (Quadrivalent):</strong> Covers HPV serotypes 6, 11, 16, and 18.</span></li><li><span style=\"font-size:12pt;\"><strong>Gardasil 9 (Nonavalent or HPV9):</strong> Covers HPV serotypes 6, 11, 16, 18, 31, 33, 45, 52, and 58.</span></li><li><span style=\"font-size:12pt;\"><strong>Cervavac (India’s indigenous HPV vaccine):</strong> Quadrivalent, covers serotypes 6, 11, 16, and 18.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Biovac:</strong> This is a vaccine for Hepatitis A, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Rabivac:</strong> This is a rabies vaccine for animals, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Tvac:</strong> This is a tetanus vaccine, not related to HPV or cervical cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Gardasil is the preferred vaccine for preventing cervical cancer and related HPV diseases, covering serotypes 6, 11, 16, and 18.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/teams/immunization-vaccines-and-biologicals/diseases/human-papillomavirus-vaccines-(HPV)</u></strong></span></a></p>",
      "correct_choice_id": 23386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5928,
      "choices": [
        {
          "id": 23682,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mandatory episiotomy</span></span></span></p>"
        },
        {
          "id": 23683,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Manual perineal support and warm compresses</span></span></span></p>"
        },
        {
          "id": 23684,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Maintain head in deflexion and deliver</span></span></span></p>"
        },
        {
          "id": 23685,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deliver in lithotomy position only</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is recommended by the WHO for the management of the second stage of labor?&nbsp;</span></span>(INICET MAY 2021)</p>",
      "unique_key": "Q5516794",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585238,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Manual perineal support and warm compresses</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The WHO guidelines for managing the second stage of labor emphasize techniques to reduce perineal trauma and enhance maternal comfort. The use of manual perineal support and warm compresses is recommended to protect the perineum during delivery and reduce the incidence of severe perineal tears.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Manual Perineal Support and Warm Compresses:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Manual Support:</span></strong><span style=\"font-size:12.0pt\"> Hands-on guarding of the perineum during delivery helps control the speed of delivery and reduces the risk of severe perineal tears.</span></span></span></li>\r\n\t\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Warm Compresses:</span></strong><span style=\"font-size:12.0pt\"> Applying warm compresses to the perineum can help relax the tissues and make them more pliable, further reducing the risk of tearing.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Mandatory Episiotomy:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Not Recommended:</span></strong><span style=\"font-size:12.0pt\"> Routine episiotomy is no longer recommended by the WHO. It is only indicated in specific cases where it is necessary to expedite delivery for the safety of the mother or baby.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Maintain Head in Deflexion and Deliver:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Not Recommended:</span></strong><span style=\"font-size:12.0pt\"> The recommendation is to allow the fetal head to assume the most optimal position for delivery rather than intentionally maintaining deflexion, which may hinder the delivery process.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Deliver in Lithotomy Position Only:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Not Recommended:</span></strong><span style=\"font-size:12.0pt\"> The WHO supports a variety of birthing positions based on the mother&rsquo;s preference and comfort. Restricting delivery to the lithotomy position is not recommended; instead, women should be encouraged to choose their preferred position.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Manual perineal support and warm compresses are recommended by the WHO to reduce perineal trauma during the second stage of labor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref:&nbsp;</span></strong><a href=\"https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-size:12.0pt\">https://iris.who.int/bitstream/handle/10665/337693/9789240017566-eng.pdf</span></strong></a></span></span></p>",
      "correct_choice_id": 23683,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5798,
      "choices": [
        {
          "id": 23163,
          "text": "<p><span style=\"font-size:12pt;\">Elevated B-hCG, PAPP-A and lower estriol, AFP</span></p>"
        },
        {
          "id": 23164,
          "text": "<p><span style=\"font-size:12pt;\">Elevated B-hCG, Inhibin and lower estriol, AFP</span></p>"
        },
        {
          "id": 23165,
          "text": "<p><span style=\"font-size:12pt;\">Lower -CG, PAPP-A and elevated estriol, AFP</span></p>"
        },
        {
          "id": 23166,
          "text": "<p><span style=\"font-size:12pt;\">Lower B-hCG, Inhibin and elevated estriol, AFP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following changes can be seen in the quadruple screening for Down syndrome?&nbsp;</span>(INICET MAY 2018)</p>",
      "unique_key": "Q8063026",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585237,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Elevated B-hCG, Inhibin and lower estriol, AFP</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The triple and quadruple test is done between 15 – 21 weeks.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Components of Triple test are: Free β hCG, unconjugated Estriol (uE3) and Maternal Serum α-fetoprotein.</span></li><li><span style=\"font-size:12pt;\">Components of the Quadruple test are: Free β hCG, unconjugated Estriol (uE3), Maternal Serum α-fetoprotein. And Inhibin A.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-152106.jpg\" alt=\"\" width=\"1000\" height=\"198\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Easy to remember</strong>: <strong>B</strong> for <strong>B</strong>ig; so in Down’s syndrome; <strong>B</strong>eta hCG and Inhi<strong>B</strong>in A: <strong>B</strong>ig/ Increased</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Elevated B-hCG, PAPP-A and lower estriol, AFP:</strong> This combination is not correct as PAPP-A is not part of the quadruple test and it typically decreases in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Lower B-hCG, PAPP-A and elevated estriol, AFP:</strong> This combination is not correct for Down syndrome. β hCG and Inhibin A are elevated in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Lower B-hCG, Inhibin and elevated estriol, AFP:</strong> This combination is not correct for Down syndrome. β hCG and Inhibin A are elevated in Down syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In Down syndrome (Trisomy 21), the quadruple test shows elevated β hCG and Inhibin A, and decreased AFP and uE3.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 863, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23164,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5830,
      "choices": [
        {
          "id": 23290,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&#39;s syndrome</span></span></span></p>"
        },
        {
          "id": 23291,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rotor syndrome</span></span></span></p>"
        },
        {
          "id": 23292,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prolactinoma</span></span></span></p>"
        },
        {
          "id": 23293,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acromegaly</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman presents to the OPD with complaints of amenorrhoea for the past year. She has a history of postpartum hemorrhage and lactational failure. What is the probable diagnosis?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;(NEET PG 2020)</span></span></span></p>",
      "unique_key": "Q8451060",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585251,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sheehan&rsquo;s syndrome </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The clinical scenario points to a diagnosis of Sheehan&#39;s syndrome.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When postpartum hemorrhage causes vascular thrombosis of the pituitary vessels (pituitary apoplexy) and panhypopituitarism. It is characterized by: </span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactation failure - due to prolactin deficiency</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amenorrhea - due to anovulation caused by reduced gonadotropin activity</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loss of sexual and axillary hair</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypothyroidism - due to decreased TSH secretion</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adrenal insufficiency - due to low ACTH</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Rotor Syndrome</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Also known as Rotor type hyperbilirubinemia, is an autosomal recessive disease and a rare cause of mixed direct (conjugated) and indirect (unconjugated) hyperbilirubinemia. The disease is characterized by non-hemolytic jaundice due to chronic elevation of predominantly conjugated bilirubin</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Prolactinoma</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This will not present lactation failure. Instead, there will be galactorrhea and symptoms like headache, luring of vision due to pressure effects of the prolactinoma. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Acromegaly</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: It is a disorder that results in excess growth of certain parts of the human body. It is caused by excess&nbsp;growth hormone&nbsp;(GH) after the&nbsp;growth plates&nbsp;have closed. The initial symptom is typically enlargement of the hands and feet.&nbsp;There may also be an enlargement of the forehead, jaw, and nose. Other symptoms may include&nbsp;joint pain, thicker skin, deepening of the voice,&nbsp;headaches, and&nbsp;problems with vision. Complications of the disease may include&nbsp;type 2 diabetes,&nbsp;sleep apnea, and&nbsp;high blood pressure. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sheehan&rsquo;s syndrome is characterized by postpartum hemorrhage leading to vascular thrombosis of the pituitary vessels, resulting in panhypopituitarism with symptoms like lactation failure and amenorrhea.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 458, DC Dutta&rsquo;s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 23290,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6058,
      "choices": [
        {
          "id": 24202,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual abstinence for 3 months and avoid pregnancy for a year</span></span></span></p>"
        },
        {
          "id": 24203,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual abstinence for 3 weeks and avoid pregnancy for 6 months</span></span></span></p>"
        },
        {
          "id": 24204,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual abstinence for 6 weeks and avoid pregnancy for a year</span></span></span></p>"
        },
        {
          "id": 24205,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sexual abstinence for 6 months and avoid pregnancy for 6 years</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While discharging a patient who underwent a vesicovaginal fistula repair, which of the following would you recommend?</span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">&nbsp;</span></span></span>(NEET PG 2022)</p>",
      "unique_key": "Q1057526",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585239,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Sexual abstinence for 3 months and avoid pregnancy for a year</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Vesicovaginal fistula (VVF) is a type of urinary fistula that commonly arises due to obstetric trauma.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Small fistulas can heal spontaneously; however, most established fistulas require surgical repair.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The surgical repair is usually performed vaginally after approximately 3 months to allow inflammation to subside.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-operatively, continuous bladder drainage for 14 days along with antibiotics is recommended to facilitate healing.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following VVF repair, it is recommended that the patient abstain from sexual activity for 3 months to allow the surgical site to heal properly and avoid complications.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Additionally, pregnancy should be avoided for a year to ensure the integrity and strength of the repair before subjecting the area to the stresses of pregnancy and childbirth.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Sexual abstinence for 3 weeks and avoid pregnancy for 6 months</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This duration of abstinence is too short for the proper healing of the surgical site. Additionally, avoiding pregnancy for only 6 months might not provide sufficient time for the repair to gain adequate strength.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Sexual abstinence for 6 weeks and avoid pregnancy for a year</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While the recommendation to avoid pregnancy for a year is appropriate, 6 weeks of sexual abstinence may still be insufficient for optimal healing of the fistula repair.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Sexual abstinence for 6 months and avoid pregnancy for 6 years</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This recommendation is excessively long. While prolonged abstinence can prevent complications, a 6-month period is more than what is typically necessary. Similarly, avoiding pregnancy for 6 years is overly cautious.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Following vesicovaginal fistula repair, patients should be advised to abstain from sexual activity for 3 months and avoid pregnancy for a year to ensure proper healing and reduce the risk of complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page 439, DC Dutta&rsquo;s Textbook of Gynecology, 6<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5746,
      "choices": [
        {
          "id": 22956,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Single dose of 0.75 after 12 hrs</span></span></span></p>"
        },
        {
          "id": 22957,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Two doses 12 hrs apart</span></span></span></p>"
        },
        {
          "id": 22958,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Three doses 12 hrs apart</span></span></span></p>"
        },
        {
          "id": 22959,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For emergency contraception, a single tab of 0.75 mg of LNG was taken, it should be followed by which of the following?&nbsp;</span></span><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(INICET NOV 2017)</span></span></span></span></p>",
      "unique_key": "Q9972601",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585270,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Single dose of 0.75 after 12 hrs</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In this case, the 2nd dose of LNG 0.75 mg (levonorgestrel) is taken after 12 hours.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">One tablet of LNG 0.75mg should be taken within 72 hours of unprotected intercourse and another 12 hours later. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alternately, two tablets (of 0.75mg) or a single 1.5mg tablet can be taken as a single dose. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The tablets can be offered up to 72h of an act of unprotected intercourse, but the efficacy decreases with the longer coital-drug interval.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other emergency contraceptives available: </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-094530.png\" style=\"height:301px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Emergency contraception using levonorgestrel requires a follow-up dose of 0.75 mg taken 12 hours after the initial dose to ensure efficacy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 243, Berek and Novak&rsquo;s Gynecology 15<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 22956,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6007,
      "choices": [
        {
          "id": 23998,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MgSO<sub>4</sub> causes uterine relaxation, but is dose dependent</span></span></span></p>"
        },
        {
          "id": 23999,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MgSO<sub>4</sub> is continued upto 24 hours after delivery or last attack of seizure</span></span></span></p>"
        },
        {
          "id": 24000,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP</span></span></span></p>"
        },
        {
          "id": 24001,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In renal failure, MgSO4 loading dose can be given, but maintenance dose should be adjusted based on renal function</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statements regarding MgSO<sub>4</sub> is false?&nbsp;</span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q5045549",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585273,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) It has inhibitory effect on cerebral cortex thereby preventing seizures and lowering the BP</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The statement that MgSO4 has an inhibitory effect on the cerebral cortex thereby preventing seizures and lowering the BP is false. MgSO4 is indeed effective in preventing seizures, particularly in the context of eclampsia, due to its action on the cerebral cortex. However, it does not lower blood pressure. Instead, its primary role is as an anticonvulsant and a tocolytic (uterine relaxant), not as an antihypertensive agent. MgSO4&rsquo;s role in managing hypertension is minimal, and it is not used specifically for blood pressure control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. MgSO4 causes uterine relaxation, but is dose dependent:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is true. MgSO4 is used as a tocolytic to relax the uterus in a dose-dependent manner. It helps in managing preterm labor by relaxing uterine contractions.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. MgSO4 is continued up to 24 hours after delivery or the last attack of seizure:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is true. Magnesium sulfate is continued for 24 hours after delivery or the last seizure to prevent recurrence of seizures and to provide adequate time for stabilization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. In renal failure, MgSO4 loading dose can be given, but the maintenance dose should be adjusted based on renal function:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This statement is true. In patients with renal failure, the loading dose of MgSO4 can be given, but the maintenance dose should be carefully adjusted due to impaired excretion of magnesium, which could lead to toxicity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MgSO4 is used for preventing seizures in eclampsia and causes uterine relaxation but does not lower blood pressure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Page no 1867, Williams Obstetrics 26<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 24000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5874,
      "choices": [
        {
          "id": 23466,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Malformations</span></span></span></p>"
        },
        {
          "id": 23467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Polyhydramnios</span></span></span></p>"
        },
        {
          "id": 23468,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fetal Macrosomia</span></span></span></p>"
        },
        {
          "id": 23469,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Neonatal Hypoglycemia</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All the followings are seen in Gestational Diabetes Mellitus except:&nbsp;</span></span></span>(INICET NOV 2019)</p>",
      "unique_key": "Q5655355",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585271,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Malformations</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital malformations are not typically seen with Gestational Diabetes Mellitus (GDM); they are more associated with pre-existing overt diabetes mellitus. When diabetes is present and uncontrolled in the first trimester, particularly with an HbA1C greater than 10%, there is a higher risk of congenital malformations. The most commonly affected system is cardiac, with Ventricular Septal Defect (VSD) being the most common anomaly. A very rare but characteristic anomaly associated with severe diabetes is Mermaid syndrome (sirenomelia).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Polyhydramnios:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Polyhydramnios, characterized by an Amniotic Fluid Index (AFI) greater than 25 or a Single Deepest Pocket (SDP) greater than 8, is common in pregnancies complicated by GDM. It results from increased fetal urination due to hyperglycemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Fetal Macrosomia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Fetal macrosomia, defined as a birth weight greater than 4 kg, is a common complication of GDM. It is associated with excessive fat deposition, particularly around the shoulders, increasing the risk of shoulder dystocia during delivery.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Neonatal Hypoglycemia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Neonatal hypoglycemia, with blood glucose levels less than 45 mg/dl, is common in infants of mothers with GDM, especially if maternal blood sugar levels were unstable during labor. This occurs because the fetus produces excess insulin in response to maternal hyperglycemia, leading to low blood sugar levels after birth.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Congenital anomalies are not typically seen with Gestational Diabetes Mellitus (GDM); they are associated with pre-existing overt diabetes mellitus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: William&rsquo;s textbook of obstetrics 26<sup>th</sup> edition pg 2787</span></strong></span></span></p>",
      "correct_choice_id": 23466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5882,
      "choices": [
        {
          "id": 23498,
          "text": "<p><span style=\"font-size:12pt;\">2cm</span></p>"
        },
        {
          "id": 23499,
          "text": "<p><span style=\"font-size:12pt;\">4cm</span></p>"
        },
        {
          "id": 23500,
          "text": "<p><span style=\"font-size:12pt;\">5cm</span></p>"
        },
        {
          "id": 23501,
          "text": "<p><span style=\"font-size:12pt;\">6cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A nursing assistant posted in the obstetric care unit was asked to plot a partograph to monitor the progress of labour. After how much dilatation of the cervix, should she start plotting the graph?&nbsp;</span>(INICET MAY 2020)</p>",
      "unique_key": "Q5710698",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585275,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 4cm</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">In the WHO modified partograph, labor ((Cervical dilatation vs time) &nbsp;is plotted on a graph and analysis includes use of action lines and alert lines.</span></li><li><span style=\"font-size:12pt;\">In the WHO modified partograph, the plotting starts in active phase (4cm)</span></li><li><span style=\"font-size:12pt;\">The alert line is plotted at a cervical dilatation rate of 1cm/h</span></li><li><span style=\"font-size:12pt;\">The action line is plotted 4h to the right of the alert line</span></li><li><span style=\"font-size:12pt;\">&nbsp;The 1<sup>st</sup> marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">The WHO modified partograph has now been replaced by the WHO labor care guide where the new definition of active labor is 5 cm so when answering a question read carefully what is asked – WHO modified partograph or WHO Labor care guide</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Plotting on the partograph should start at 4 cm cervical dilatation during the active phase of labor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 152, DC Dutta’s Textbook of Obstetrics 7<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5966,
      "choices": [
        {
          "id": 23834,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 23835,
          "text": "<p><span style=\"font-size:12pt;\">Laparoscopy and metroplasty</span></p>"
        },
        {
          "id": 23836,
          "text": "<p><span style=\"font-size:12pt;\">Hysteroscopy and septoplasty</span></p>"
        },
        {
          "id": 23837,
          "text": "<p><span style=\"font-size:12pt;\">Laparotomy and metroplasty</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old married woman who came for the evaluation of infertility was found to have a septum in her uterine cavity. What would be the appropriate management of this case? (NEET PG 2021)</span></p>",
      "unique_key": "Q7432914",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585255,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Hysteroscopy and septoplasty</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>&nbsp;Hysteroscopy and septoplasty:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">Uterine septum is a Mullerian anomaly where the uterine cavity is completely or partially separated by a septum. This can lead to infertility, recurrent abortions, preterm labor, fetal growth restriction, malpresentations, and retained placenta.</span></li><li><span style=\"font-size:12pt;\">The diagnosis of a uterine septum can be confirmed through hysterosalpingography (HSG), 3D ultrasound, MRI, or hysteroscopy. Hysteroscopy is the gold standard for both diagnosis and treatment.</span></li><li><span style=\"font-size:12pt;\">Hysteroscopic resection (septoplasty) is the appropriate management as it involves minimally invasive surgery to remove the septum, which improves reproductive outcomes.</span></li></ul><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/6.jpg\" alt=\"\" width=\"700\" height=\"298\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Hysterectomy:</strong> Hysterectomy, the removal of the uterus, is not an appropriate management for a uterine septum in a woman desiring fertility. This would completely eliminate her ability to conceive and carry a pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Laparoscopy and metroplasty:</strong> While laparoscopy can be used to visualize the external uterine anatomy, metroplasty (surgical correction of the uterus) is better performed via hysteroscopy for a uterine septum. Laparoscopy is more invasive and not the first-line approach for this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Laparotomy and metroplasty:</strong> Laparotomy is an open surgical procedure that involves a larger incision in the abdomen. This approach is unnecessarily invasive for the correction of a uterine septum, which can be effectively managed with a less invasive hysteroscopic approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The appropriate management of a uterine septum, especially in a woman seeking fertility, is hysteroscopic resection (septoplasty), which involves minimally invasive surgery to remove the septum and improve reproductive outcomes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 47, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23836,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5831,
      "choices": [
        {
          "id": 23294,
          "text": "<p><span style=\"font-size:12pt;\">Tuberculosis with tubo-ovarian mass</span></p>"
        },
        {
          "id": 23295,
          "text": "<p><span style=\"font-size:12pt;\">Ovarian malignancy</span></p>"
        },
        {
          "id": 23296,
          "text": "<p><span style=\"font-size:12pt;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 23297,
          "text": "<p><span style=\"font-size:12pt;\">Submucous fibroid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An 18-year-old girl presents with a history of low-grade fever, weight loss, abdominal pain and amenorrhea for six months. On examination, a pelvic mass is felt on the left side and signs of ascites are positive. What is your diagnosis?&nbsp;(NEET PG 2020)</span></p>",
      "unique_key": "Q1686214",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585252,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Tuberculosis with tubo-ovarian mass</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\">This is the most likely diagnosis in view of the following points</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12pt;\">Age</span></li><li><span style=\"font-size:12pt;\">Symptoms: low grade fever, weight loss, pain and amenorrhoea</span></li><li><span style=\"font-size:12pt;\">Adnexal mass with ascites</span></li></ul></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ovarian malignancy</strong>: Ovarian malignancy may present with weight loss, ascites and a pelvic mass. But a young age and amenorrhea do not go in favor of ovarian malignancy</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Ectopic pregnancy</strong>: Ectopic pregnancy will be an acute presentation and will not present with fever/ weight loss</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Submucous fibroid</strong>: Submucous fibroid presents with menorrhagia/ inter-menstrual bleeding and the uterus will be uniformly enlarged. There will not be any pelvic mass.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tuberculosis with a tubo-ovarian mass is suspected in young patients presenting with low-grade fever, weight loss, amenorrhea, and a pelvic mass with signs of ascites.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 141, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23294,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5815,
      "choices": [
        {
          "id": 23230,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unmotivated patient</span></span></span></p>"
        },
        {
          "id": 23231,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Menorrhagia</span></span></span></p>"
        },
        {
          "id": 23232,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous ectopic pregnancy</span></span></span></p>"
        },
        {
          "id": 23233,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Previous history of abortion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following would be considered as an absolute contraindication for insertion of copper T to a patient?&nbsp;</span></span>(INICET NOV 2018)</p>",
      "unique_key": "Q3361062",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585247,
      "difficulty_level": "intermediate",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Unmotivated patient</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inserting a copper T intrauterine device (IUD) requires the patient to be motivated and consent to the procedure. An unmotivated patient or one who does not consent should never undergo the procedure. This is because the successful use of an IUD requires patient understanding, willingness to comply with follow-up care, and adherence to guidelines for managing any potential side effects or complications.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Absolute contraindications for the use of copper IUDs include:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Unexplained uterine or vaginal bleeding</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Post-abortal sepsis, puerperal sepsis, current pelvic inflammatory disease (PID), or genital tuberculosis</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Cancers such as endometrial cancer, cervical cancer, and gestational trophoblastic neoplasia</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Large fibroids distorting the uterine cavity or Mullerian anomalies distorting the uterine cavity</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Menorrhagia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While menorrhagia is a relative contraindication, as the copper IUD can exacerbate heavy menstrual bleeding, it is not an absolute contraindication.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Previous ectopic pregnancy:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A history of ectopic pregnancy is a consideration but not an absolute contraindication for copper IUD use.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Previous history of abortion:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A previous history of abortion is not an absolute contraindication for the insertion of a copper IUD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An unmotivated patient or one who does not consent is an absolute contraindication for the insertion of a copper T intrauterine device (IUD).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ref: Dutta&rsquo;s textbook of gynecology 6th edition pg 480</span></strong></span></span></p>",
      "correct_choice_id": 23230,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 55313,
      "choices": [
        {
          "id": 220713,
          "text": "<p><span style=\"font-size:12.0pt;\">10 mins</span></p>"
        },
        {
          "id": 220714,
          "text": "<p><span style=\"font-size:12.0pt;\">24h</span></p>"
        },
        {
          "id": 220715,
          "text": "<p><span style=\"font-size:12.0pt;\">48h</span></p>"
        },
        {
          "id": 220716,
          "text": "<p><span style=\"font-size:12.0pt;\">7 days</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Post-partum IUCD insertion can be inserted till? (FMGE JULY 2024)</span></p>",
      "unique_key": "Q6055173",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585231,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 48h</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postpartum IUCD (Intrauterine Contraceptive Device) insertion is classified into early postpartum and late postpartum insertion.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Early Postpartum IUCD (PPIUCD):</strong> This can be further divided into:</span><br>&nbsp;<ul><li><span style=\"font-size:12.0pt;\"><strong>Within 10 minutes of placental delivery:</strong> This is known as immediate PPIUCD insertion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>After 10 minutes but within 48 hours of delivery:</strong> This is still considered early postpartum insertion and can be performed either after vaginal delivery or during a cesarean section.</span><br>&nbsp;</li></ul></li></ul><p><span style=\"font-size:12.0pt;\">If the IUCD is not inserted within this 48-hour window, it cannot be inserted until after six weeks postpartum. This period between 48 hours and six weeks is a contraindicated window for IUCD insertion due to the increased risk of expulsion and complications.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Late Postpartum IUCD:</strong> This insertion is done after six weeks postpartum.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Postpartum IUCD can be inserted <strong>within 48 hours of delivery or after six weeks postpartum</strong>. The period between 48 hours and six weeks is contraindicated for IUCD insertion.</span></p>",
      "correct_choice_id": 220715,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5883,
      "choices": [
        {
          "id": 23502,
          "text": "<p><span style=\"font-size:12pt;\">Pawlik's grip</span></p>"
        },
        {
          "id": 23503,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Lateral grip</span></p>"
        },
        {
          "id": 23504,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Pelvic grip</span></p>"
        },
        {
          "id": 23505,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Fundal grip</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the grip shown in the image below:&nbsp;</span>(INICET MAY 2020)</p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-may-2020-1.jpg\" alt=\"\" width=\"300\" height=\"318\"></p><p>&nbsp;</p>",
      "unique_key": "Q9505024",
      "question_audio": null,
      "question_video": null,
      "map_id": 32585276,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Lateral grip</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Obstetric grips (Leopold manoeuvres)</span></p><p>&nbsp;</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12pt;\">Fundal grip (1st Leopold)</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿Lateral/umbilical grip (2nd Leopold)</span></li><li><span style=\"font-size:12pt;\">﻿﻿﻿1st pelvic grip /Pawlik grip (3rd Leopold)</span></li><li><span style=\"font-size:12pt;\">2nd pelvic grip (4th Leopold)</span></li></ol><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/whatsapp-image-2023-10-02-at-122945.jpeg\" alt=\"\" width=\"500\" height=\"601\"></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The <strong>Lateral grip</strong>, also known as the <strong>Umbilical grip</strong> or <strong>Second Leopold's maneuver</strong>, is used to assess the position of the fetus in the uterus by palpating the sides of the maternal abdomen. This grip helps determine the location of the fetal back and limbs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Pawlik's grip</strong>: Also known as the <strong>First pelvic grip</strong> or <strong>Third Leopold's maneuver</strong>, Pawlik's grip involves palpating the lower uterine segment to determine the fetal presenting part (e.g., whether it is a head or breech presentation).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Pelvic grip</strong>: This term is sometimes used to refer to the <strong>Second pelvic grip</strong> or <strong>Fourth Leopold's maneuver</strong>, which is used to assess the fetal engagement and the degree of descent in the pelvic cavity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Fundal grip</strong>: This is the <strong>First Leopold's maneuver</strong>, which involves palpating the upper part of the uterus (fundus) to identify the fetal presentation (e.g., head or breech) and the lie of the fetus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The Lateral grip (Second Leopold's maneuver) is used to assess the position of the fetal back and limbs by palpating the sides of the maternal abdomen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Ref: Page 89, DC Ditta’s Textbook of Obstetrics 8<sup>th</sup> edition.</strong></span></p>",
      "correct_choice_id": 23503,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}